<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS201670</article-id><article-id pub-id-type="doi">10.1101/2024.11.29.626085</article-id><article-id pub-id-type="archive">PPR949112</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>DNA methylation and gene expression trajectories of human postprandial metabolism</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Costeira</surname><given-names>Ricardo</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ruiz</surname><given-names>Lidia Daimiel</given-names></name><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Gehrmann</surname><given-names>Thies</given-names></name><xref ref-type="aff" rid="A4">4</xref><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Bogaards</surname><given-names>Fatih</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Villicaña</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sinke</surname><given-names>Lucy</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Raza</surname><given-names>Yasrab</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tomlinson</surname><given-names>Max</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A6">6</xref></contrib><contrib contrib-type="author"><name><surname>Christiansen</surname><given-names>Colette</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Heijmans</surname><given-names>Bastiaan T</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Slagboom</surname><given-names>P Eline</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Spector</surname><given-names>Tim D</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Small</surname><given-names>Kerrin S</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Alcala-Diaz</surname><given-names>Juan F</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A7">7</xref><xref ref-type="aff" rid="A8">8</xref><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Rangel-Zuñiga</surname><given-names>Oriol</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A7">7</xref><xref ref-type="aff" rid="A8">8</xref><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>López-Miranda</surname><given-names>Jose</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A7">7</xref><xref ref-type="aff" rid="A8">8</xref><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Waldenberger</surname><given-names>Melanie</given-names></name><xref ref-type="aff" rid="A10">10</xref><xref ref-type="aff" rid="A11">11</xref></contrib><contrib contrib-type="author"><name><surname>Berry</surname><given-names>Sarah E</given-names></name><xref ref-type="aff" rid="A12">12</xref></contrib><contrib contrib-type="author"><name><surname>Ordovás</surname><given-names>José M</given-names></name><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A13">13</xref><xref ref-type="aff" rid="A14">14</xref><xref ref-type="aff" rid="A15">15</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bell</surname><given-names>Jordana T</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Twin Research and Genetic Epidemiology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>King’s College London</institution></institution-wrap>, <city>London</city><postal-code>SE1 7EH</postal-code>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label>Nutritional Control of the Epigenome, Precision Nutrition and Obesity Program IMDEA Food, CEI UAM + <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02gfc7t72</institution-id><institution>CSIC</institution></institution-wrap>, <city>Madrid</city>, <country country="ES">Spain</country></aff><aff id="A3"><label>3</label>Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), <institution-wrap><institution-id institution-id-type="ror">https://ror.org/00ca2c886</institution-id><institution>Institute of Health Carlos III</institution></institution-wrap>, <city>Madrid</city>, <country country="ES">Spain</country></aff><aff id="A4"><label>4</label>Molecular Epidemiology, Department of Biomedical Data Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05xvt9f17</institution-id><institution>Leiden University Medical Center</institution></institution-wrap>, <city>Leiden</city><postal-code>2333 ZC</postal-code>, <country country="NL">The Netherlands</country></aff><aff id="A5"><label>5</label>Department of Bioscience Engineering, Lab of Applied Microbiology and Biotechnology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/008x57b05</institution-id><institution>University of Antwerp</institution></institution-wrap>, <city>Antwerp</city><postal-code>2020</postal-code>, <country country="BE">Belgium</country></aff><aff id="A6"><label>6</label>Department of Medical and Molecular Genetics, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>King’s College London</institution></institution-wrap>, <city>London</city><postal-code>SEI 9RT</postal-code>, <country country="GB">UK</country></aff><aff id="A7"><label>7</label>Lipids and Atherosclerosis Unit, Department of Internal Medicine, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02vtd2q19</institution-id><institution>Hospital Universitario Reina Sofía</institution></institution-wrap>, <city>Cordoba</city>, <country country="ES">Spain</country></aff><aff id="A8"><label>8</label>Department of Medical and Surgical Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05yc77b46</institution-id><institution>Universidad de Cordoba</institution></institution-wrap>, <city>Cordoba</city>, <country country="ES">Spain</country></aff><aff id="A9"><label>9</label>Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Cordoba, Spain</aff><aff id="A10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/031t5w623</institution-id><institution>German Research Center for Cardiovascular Disease (DZHK)</institution></institution-wrap>, Partner Site Munich Heart Alliance, <postal-code>80802</postal-code><city>Munich</city>, <country country="DE">Germany</country></aff><aff id="A11"><label>11</label>Research Unit Molecular Epidemiology, Institute of Epidemiology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cfam450</institution-id><institution>Helmholtz Zentrum München, German Research Center for Environmental Health</institution></institution-wrap>, <postal-code>85764</postal-code><city>Neuherberg</city>, <country country="DE">Germany</country></aff><aff id="A12"><label>12</label>Department of Nutritional Sciences, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>King’s College London</institution></institution-wrap>, <city>London</city><postal-code>SE1 9NH</postal-code>, <country country="GB">UK</country></aff><aff id="A13"><label>13</label>Nutrition and Genomics Laboratory, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01d0zz505</institution-id><institution>Jean Mayer USDA Human Nutrition Center on Aging</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/05wvpxv85</institution-id><institution>Tufts University</institution></institution-wrap>, <city>Boston</city>, <postal-code>MA 02111</postal-code>, <country country="US">USA</country></aff><aff id="A14"><label>14</label>Nutritional Genomics and Epigenomics Group, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04g4ezh90</institution-id><institution>IMDEA-Food</institution></institution-wrap>, <postal-code>28049</postal-code><city>Madrid</city>, <country country="ES">Spain</country></aff><aff id="A15"><label>15</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03f6h9044</institution-id><institution>University Camilo José Cela</institution></institution-wrap>, <city>Villafranca del Castillo</city>, <postal-code>28692</postal-code><city>Madrid</city>, <country country="ES">Spain</country></aff><author-notes><corresp id="CR1">
<label>*</label>Corresponding author: <email>jordana.bell@kcl.ac.uk</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>05</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>03</day><month>12</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Human postprandial metabolism is characterised by a highly individualised response to food that is predictive of cardiometabolic health and underexplored at the molecular level. We profiled blood DNA methylation (DNAm) and gene expression trajectories before and after a test meal in 225 European participants. We identify DNAm changes at fasting, 30 minutes and 4 hours after meal challenge, including in metabolically relevant genes <italic>INPP4A, GHRL, ASIP</italic> and <italic>ABCG1,</italic> with changes observed as early as 30mins postprandially. Gene expression trajectories also changed postprandially predominantly at 4 hours, with replication of lipid metabolism (<italic>CPT1A</italic>) and circadian rhythm (<italic>PER1</italic>) genes. Genetic variants affect postprandial molecular trajectories at genes linked to obesity (<italic>PDE9A</italic>) and glucose response (<italic>GPT2</italic>). Multiple signals associated with postprandial glucose and triglyceride levels, with replication of <italic>CPT1A</italic> methylation. The postprandial DNAm and expression trajectories target metabolically relevant genes, giving insights towards mechanisms underlying inter-individual response to food and cardiometabolic disease risk.</p></abstract><kwd-group><kwd>epigenetics</kwd><kwd>DNA methylation</kwd><kwd>gene expression</kwd><kwd>postprandial metabolism</kwd><kwd>cardiometabolic health</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2">The postprandial state, defined as the 0–8-hour period following a meal, is characterised by highly individualised responses to food in humans<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Intra- and inter-individual variation observed in the glycemic and lipemic responses to food are associated with poor cardiometabolic health outcomes, including type 2 diabetes and an increased risk of cardiovascular events<sup><xref ref-type="bibr" rid="R2">2</xref></sup>. Postprandial oxidative stress and inflammation partly mediate the acute effect of foods on disease risk<sup><xref ref-type="bibr" rid="R2">2</xref></sup>. However, the molecular mechanisms associated with the postprandial state in humans are still not well understood. Epigenetic regulation of gene expression, particularly through DNA methylation (DNAm) at CpG sites, may play a role in postprandial metabolism.</p><p id="P3">DNAm is a major regulator of gene expression in humans<sup><xref ref-type="bibr" rid="R3">3</xref></sup>, and is responsive to various stimuli, including food<sup><xref ref-type="bibr" rid="R4">4</xref></sup>. Despite this, human studies on postprandial DNAm are limited. So far, one larger scale study identified DNAm signals at fasting to be associated with postprandial triglyceride concentrations<sup><xref ref-type="bibr" rid="R5">5</xref></sup>, highlighting key metabolic genes such as <italic>CPT1A, ABCG1,</italic> and <italic>SREBF1.</italic> Two smaller scale studies further explored DNAm longitudinally over the postprandial phase, in 26 healthy males at baseline fasting and 160 minutes (m) postprandially<sup><xref ref-type="bibr" rid="R6">6</xref></sup>, and in 12 males across different BMI categories from baseline up to 10 hours (h) postprandially<sup><xref ref-type="bibr" rid="R7">7</xref></sup>. The results revealed that changes in blood DNAm are partially mediated by shifts in blood cell proportions and that DNAm associations with BMI and fatty acid concentrations differ between fasting and postprandial states.</p><p id="P4">While DNAm studies offer insights into the epigenetic landscape of the postprandial state, transcriptomic research has also identified changes in postprandial gene expression. Multiple studies have identified changes in postprandial expression levels of immune, inflammatory and circadian rhythm genes, such as <italic>PER1</italic>, and body-weight dependent metabolic responses to food, but results are often context-specific and limited to small samples<sup><xref ref-type="bibr" rid="R8">8</xref>–<xref ref-type="bibr" rid="R12">12</xref></sup>. More recently, the larger Growing Old Together study (GOTO)<sup><xref ref-type="bibr" rid="R13">13</xref></sup> identified postprandial blood gene expression levels from fasting to 30m postprandially <sup><xref ref-type="bibr" rid="R14">14</xref></sup>. This was carried out both pre- and post- a combined nutritional and physical activity lifestyle intervention in 85 participants, and identified changes in stress response genes, with stronger effects observed in males <sup><xref ref-type="bibr" rid="R14">14</xref></sup>.</p><p id="P5">Despite significant advances, a comprehensive understanding of how DNAm and gene expression change over the postprandial state remains elusive, particularly in large and diverse human populations. In this study, we characterize human blood DNAm and gene expression trajectories at fasting and over the postprandial state (30m to capture peak glycemia, and 4h for peak lipemia) in 225 participants from two large-scale European postprandial cohort studies, PREDICT and CORDIOPREV. We identified over a hundred molecular genomic signals that changed after test meal and characterized their links to postprandial glucose and triglyceride trajectories, which are cardiometabolic risk factors.</p></sec><sec id="S2" sec-type="results"><title>Results</title><p id="P6">We captured longitudinal DNAm and gene expression signals at fasting and postprandially at 30m and 4h after test meal (<xref ref-type="fig" rid="F1">Figure 1</xref>). DNAm differences between fasting baseline and 4h postprandially were explored by meta-analysis of the PREDICT and CORDIOPREV studies in up to 225 participants (54% males, median age = 58.8 years). The PREDICT study is a large-scale high-resolution postprandial study with 1002 participants recruited at baseline from the UK population<sup><xref ref-type="bibr" rid="R15">15</xref></sup>, where healthy participants were fed a high carbohydrate-high fat meal. We generated whole blood DNAm profiles in a subset of individuals from the PREDICT study, including 104 PREDICT female healthy participants (mean age = 58.97 ± 12.58 years), at fasting and postprandially at 30m and 4h after meal intake. CORDIOPREV (the CORonary Diet Intervention with Olive Oil and Cardiovascular PREVention study) is a randomized clinical trial involving 1002 patients with coronary disease<sup><xref ref-type="bibr" rid="R16">16</xref></sup>, where participants received a high-fat meal at baseline to assess postprandial lipemic response. We generated whole blood DNAm in a subset of CORDIOPREV individuals, including 121 male participants (mean age = 59.09 ± 9.48 years) at fasting and 4h after meal intake (<xref ref-type="table" rid="T1">Table 1</xref>). DNAm trajectories were further dissected in the PREDICT cohort alone, including 30m postprandial glycemia. Matched RNA-sequencing expression trajectories were generated in a random subset of 50 PREDICT females to explore postprandial gene expression changes. DNAm and expression trajectories were then linked to the trajectories of plasma glucose and blood triglyceride concentrations after test meal in PREDICT. Replication of the postprandial regulatory and functional genomic trajectories was undertaken using epigenetic results from postprandial studies by Lai et al. <sup><xref ref-type="bibr" rid="R5">5</xref></sup> and Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup>, as well as gene expression postprandial results from the lifestyle intervention study by Gehrmann et al<sup><xref ref-type="bibr" rid="R14">14</xref></sup>.</p><sec id="S3"><title>Longitudinal meta-analysis identifies DNA methylation signals postprandially at 4 hours</title><p id="P7">Postprandial lipemia is an independent risk factor for cardiovascular disease <sup><xref ref-type="bibr" rid="R17">17</xref></sup>. It is characterized by a rise in blood lipids after meal consumption, which peaks around 4h and returns to baseline around 8h postprandially. We aimed to identify DNAm changes that occur at this timepoint and are potentially characteristic of postprandial lipemia. To this end, we contrasted fasting baseline and 4h post-meal DNAm levels in the PREDICT and CORDIOPREV cohorts. Meta-analysis of epigenetic changes between 4h and baseline identified 108 DMPs in 78 genes at FDR 5% and after heterogeneity filters (HetISq &lt; 85% and HetPval ≥ 0.01), across the two cohorts (<xref ref-type="fig" rid="F2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="SD2">Figure S1</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S1</xref>). The peak signal was observed at cg03403093 in the 5’UTR region of <italic>INPP4A</italic> (coefficient <italic>b =</italic> 0.121 ± 0.020, <italic>p =</italic> 1.98E-09), a lipid phosphatase that negatively regulates the PI3K/Akt pathway<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. Other significant CpG signals were found in metabolically relevant genes such as <italic>ACSL6, GHRL, ASIP, SLC16A11, PDXK, ABCG1, GPT2</italic> and others (<xref ref-type="fig" rid="F2">Figure 2</xref> and <xref ref-type="supplementary-material" rid="SD2">Figures S2, S3</xref>). These include lipid metabolism genes, such as <italic>ASIP</italic> and <italic>ABCG1,</italic> a key lipid transporter<sup><xref ref-type="bibr" rid="R19">19</xref></sup>, as well as the acyl-CoA synthetase <italic>ACLS6</italic> and <italic>SLC16A11</italic> transporter, implicated in lipid synthesis and metabolism<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>. <italic>GHRL</italic> encodes the prepropeptide for ghrelin, an appetite-stimulating hormone with effects in growth hormone release from the anterior pituitary, adiposity, circadian regulation and metabolic inflammation (metaflammation)<sup><xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup>. Altogether, the <italic>ASIP, ABCG1, GHRL, ACSL6, SLC16A11, GPT2</italic> and <italic>PDXK</italic> have all been studied in the context of obesity and type 2 diabetes<sup><xref ref-type="bibr" rid="R19">19</xref>–<xref ref-type="bibr" rid="R26">26</xref></sup>, while the PI3K/Akt pathway is the main signalling pathway implicated in the relationship between these two traits<sup><xref ref-type="bibr" rid="R27">27</xref></sup>. Biological pathway and enrichment analyses of our results highlighted pathways for neuronal system activity, signal transduction and fatty acid metabolism (<xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). Enrichment analysis of phenotypes previously linked to these CpGs in the EWAS Catalog<sup><xref ref-type="bibr" rid="R28">28</xref></sup> identified enrichment for signals previously associated with BMI, waist circumference, C-reactive protein levels, and granzymes A and K (GZMA and GZMK) levels (<xref ref-type="supplementary-material" rid="SD1">Table S3</xref>). C-reactive protein is a marker of inflammation, while GZMA and GZMK are cell death–inducing enzymes stored in cytotoxic T lymphocytes and NK cells <sup><xref ref-type="bibr" rid="R21">21</xref></sup>. Other metabolic phenotypes were also linked to these CpGs in previous EWAS within the EWAS Catalog, including type 2 diabetes, and levels of glucose, triglycerides and cholesterol, but these traits did not show evidence for enrichment.</p><p id="P8">Like previous work (Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup>) we observed postprandial changes in blood cell composition in our samples (<xref ref-type="supplementary-material" rid="SD2">Figure S4</xref>). Specifically, the proportions of monocytes, granulocytes and natural killer cells changed significantly after test meal. In the epigenome-wide cohort-specific analyses, and meta-analysis, results are presented after adjustment for blood cell proportion changes. Furthermore, we profiled DNAm in CD4+ T cells from a random subset of 10 PREDICT participants (6 females and 4 males, mean age = 75.91 ± 6.12 years, mean BMI = 24.23 ± 1.36 kg/m<sup>2</sup>) and evaluated the consistency of effects across whole blood and CD4+ T cells postprandially. Of the signals that show the same direction of effect in whole blood at 4h across PREDICT, CORDIOPREV, and the subset of 10 PREDICT participants, 11 signals (41%) exhibit the same direction of effect across whole blood and CD4+ T cell populations (<xref ref-type="supplementary-material" rid="SD1">Table S4</xref>).</p><p id="P9">As a validation of the epigenome-wide meta-analysis results we also carried out analyses using unadjusted DNAm β-values. These altogether identified 175 DMPs, including 70% of signals from the main analysis based on M-values (113 DMPs total, FDR = 5%), but showed greater evidence for heterogeneity in meta-analysis. Directions of effect were overall consistent between M- and β-values (<xref ref-type="supplementary-material" rid="SD2">Figure S5</xref>). Further validation analyses in the complete sample of 265 individuals included analyses of the complete set of female and male participants across both cohorts (<xref ref-type="sec" rid="S16">Methods</xref>), and this identified 20 DMPs (FDR = 5%), 19 of which are in the primary meta-analysis results presented above.</p></sec><sec id="S4"><title>Dissection of DNA methylation and expression trajectories over the postprandial state</title><p id="P10">The CORDIOPREV study captured the response to dietary fat in coronary heart disease patients from baseline fasting to 4h postprandially alone <sup><xref ref-type="bibr" rid="R16">16</xref></sup>. In contrast, the PREDICT study captured the human response to food<sup><xref ref-type="bibr" rid="R1">1</xref></sup> from baseline fasting to both the glycemic response at 30m and the lipemic response at 4h. We therefore explored DNAm and gene expression across fasting baseline, and postprandially at 30m and 4h in the PREDICT sample alone, in order to explore the full DNAm and expression trajectories after meal.</p><sec id="S5"><title>Postprandial DNA methylation trajectories</title><p id="P11">First, using the 3 timepoints from PREDICT we explored how early after test meal the 108 DMPs captured earlier at 4h (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>) show differential DNAm in comparison to fasting DNAm levels. Of the 108 DMPs captured from PREDICT and CORDIOPREV at 4h, 95% were captured at 4h in the PREDICT trajectory analysis alone, and a subset of 40% DMPs showed DNAm changes as early as 30m after test meal (<italic>p</italic> &lt; 0.05; <xref ref-type="supplementary-material" rid="SD1">Table S5</xref>). Signals with nominal changes at 30m included cg07870237 (<italic>ACSL6),</italic> cg13681935 (<italic>ASIP</italic>) and cg14880584 (<italic>GPT2</italic>). To further dissect DNAm changes 30m after meal we extended our full trajectory analysis in PREDICT epigenome-wide.</p><p id="P12">Variability in DNAm levels across 3 timepoints (fasting baseline, 30m and 4h postprandially) was identified at 27 CpGs epigenome-wide, which annotated to 21 genes including <italic>CAMTA1, KCNIP3, PDGFRA, A4GALT, DAGLA, PDE9A</italic> and <italic>ETV5</italic> (<xref ref-type="fig" rid="F2">Figure 2C</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S6</xref>: FDR = 5%). The peak signal was cg23021268 in the body of <italic>CAMTA1 (b =</italic> -0.314 ± 0.053, <italic>p =</italic> 5.10E-08), which encodes a transcription activator that regulates insulin production and secretion<sup><xref ref-type="bibr" rid="R29">29</xref></sup>. DAGLA is a diacylglycerol lipase, <italic>A4GALT</italic> is upregulated with high salt diet <sup><xref ref-type="bibr" rid="R30">30</xref></sup>, and <italic>ETV5</italic> and <italic>PDE9A</italic> expression is associated with obesity in mice <sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref></sup>. For the majority of signals DNAm levels changed immediately 30m after meal intake, with variable patterns over the postprandial state (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Notably, <italic>CAMTA1</italic> DNAm was lowest at 30m highlighting its potential role in the glycemic response. <italic>DAGLA</italic> gene hypomethylation at cg26254678 was sustained up until 4h after a meal. Altogether, there were 108 DMPs in the meta-analysis of PREDICT and CORDIOPREV at 4h, and <italic>27</italic> DMPs in the postprandial DNAm trajectory analysis in PREDICT females alone, of which six signals overlapped. The six overlapping DMPs included cg02305853 (<italic>C20orf46</italic>), cg09873405 (<italic>NTRK1),</italic> cg10544155, cg25974996 (<italic>KCNIP3</italic>), cg00118229 (<italic>PDE9A</italic>) and cg00122255. At gene level, postprandial changes in DNAm signals were detected in 78 genes in the meta-analysis of PREDICT and CORDIOPREV at 4h, and in 21 genes in the postprandial DNAm trajectory analysis in PREDICT females alone, of which four genes overlapped; resulting in 95 unique genes that exhibit postprandial DNAm changes.</p><p id="P13">We conducted several sensitivity analyses, first, exploring the consistency of DNAm trajectories both at these 27 CpGs and at the 108 signals from the postprandial 4h meta-analysis across different DNAm quantifications. We observed that results, based on DNAm M-values, were overall consistent with the trajectories of unadjusted raw DNAm β-values (<xref ref-type="supplementary-material" rid="SD2">Figures S2-S3, S6-S7</xref>). Second, trajectories of DNAm were also consistent across whole blood and CD4+ T cells only in a subset of CpGs (<xref ref-type="supplementary-material" rid="SD2">Figure S8</xref>). Because the PREDICT sample used was composed of predominantly females (<xref ref-type="table" rid="T1">Table 1</xref>), a sensitivity analysis accounting for menopausal status and hormone replacement therapy was conducted in a subsample of 37 females with available phenotype information. Altogether, twenty-three of the 27 DMPs remained nominally significant and in the same direction of association in this subsample (85% of DMPs, <xref ref-type="supplementary-material" rid="SD1">Table S7</xref>). Finally, previous research has found that human DNAm levels can oscillate with time of day<sup><xref ref-type="bibr" rid="R33">33</xref></sup>. To ascertain that the DNAm trajectories observed were due to test meal and not time of day we interrogated the set of circadian DMPs reported by Oh et al. <sup><xref ref-type="bibr" rid="R33">33</xref></sup>. We were able to interrogate 58% of circadian DMPs and, while a few DMPs were variable at a nominal significance (<xref ref-type="supplementary-material" rid="SD1">Table S8</xref>), we did not find major evidence for circadian effect on the DMPs identified at 30m and 4h after test meal. No effect of time of day was observed for the 4h postprandial lipemia meta-analysis results either (<xref ref-type="supplementary-material" rid="SD1">Table S8</xref>).</p><p id="P14">Gene enrichment analysis of DNAm trajectory results identified 80 terms across 5 ontology/pathway databases, including regulation of transcription, signalling (<italic>e.g.:</italic> PI3K), cellular response to oxidative stress, haematopoiesis, and neurotransmission where 11% of the terms identified were directly related to brain (<xref ref-type="supplementary-material" rid="SD1">Table S9</xref>). In the EWAS Catalog we observed an enrichment for signals previously linked to immune phenotypes (<italic>e.g.:</italic> C-reactive protein, GZMK, GZMA and IL2RB) and found that some of the CpGs were previously associated with type 2 diabetes, glucose and BMI (<xref ref-type="supplementary-material" rid="SD1">Table S10</xref>).</p><p id="P15">We considered replication of the DNAm postprandial findings using previously published results<sup><xref ref-type="bibr" rid="R6">6</xref></sup>. We initially compared our results to those from Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup> in 26 males sampled at baseline and 160m after consumption of a different standardised meal. Twenty-four signals captured at 160m postprandially by Rask-Andersen et al. were nominally significant in the PREDICT sample with 9 (38%) and 13 (48%) of signals matching direction of effect at 30m and 4h in PREDICT (<xref ref-type="supplementary-material" rid="SD1">Table S11A</xref>), respectively, despite sampling at different time-points postprandially. The peak replicated signal, and only signal to pass Bonferroni correction, was cg08697116 in the body of <italic>KLK4 (b =</italic> 0.141 ± 0.045, <italic>p =</italic> 4.86e-05) with the same direction of effect at 4h postprandially. The larger meta-analysis of postprandial lipemia DNAm signals replicated 10 other signals from Rask-Andersen et al. at nominal significance (<xref ref-type="supplementary-material" rid="SD1">Table S11B</xref>), and 4 of the 24 signals already captured by PREDICT alone (<xref ref-type="supplementary-material" rid="SD1">Table S11A</xref>).</p></sec><sec id="S6"><title>Postprandial gene expression trajectories</title><p id="P16">Variability in longitudinal gene expression trajectories identified 24 differentially expressed genes over the postprandial state in a random subsample of PREDICT individuals (50 females sampled at 0-30m-4h, <xref ref-type="fig" rid="F3">Figures 3A-B</xref>, <xref ref-type="supplementary-material" rid="SD2">Figure S9</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S12</xref>: FDR = 5%). The peak differentially expressed trajectory was observed for <italic>CPT1A,</italic> which was downregulated at 4h (<italic>b =</italic> 0.183 ± 0.119, <italic>p =</italic> 6.60E-25). <italic>CPT1A</italic> encodes the key rate-limiting enzyme of fatty acid oxidation and epigenetic regulation of <italic>CPT1A</italic> expression has previously been observed with high fat<sup><xref ref-type="bibr" rid="R34">34</xref></sup>. Further differentially expressed signals included the circadian rhythm regulator <italic>PER1</italic>, recently linked to the regulation of metabolic homeostasis in fasting<sup><xref ref-type="bibr" rid="R35">35</xref></sup>, as well as genes involved in metabolism such as <italic>SLC25A20, ACAA2, AGPAT4</italic> and <italic>SQLE,</italic> and inflammation regulators <italic>PDE4D</italic> and <italic>FKBP5.</italic> While we observed variability in the shape of the postprandial DNAm trajectories (<xref ref-type="fig" rid="F2">Figure 2D</xref>), the gene expression signals were consistently heightened at 4h postprandially. Furthermore, the direction of effect was generally consistent across 30m and 4h (<xref ref-type="fig" rid="F2">Figure 2</xref>, <xref ref-type="supplementary-material" rid="SD2">Figure S10</xref> for all trajectories). Gene expression analysis of postprandial lipemia alone in PREDICT (0-4h changes) identified 21 differentially expressed genes, including 18 genes from our main gene expression trajectory analysis (75% of genes from the 0-30m-4h analysis, <xref ref-type="supplementary-material" rid="SD1">Table S12</xref>).</p><p id="P17">Sensitivity analysis was performed for gene expression using the full set of covariates from the epigenetic analyses including estimated blood cell proportions (<xref ref-type="sec" rid="S16">Methods</xref>), and all 24 expression signals remained significant with the same direction of effect (<xref ref-type="supplementary-material" rid="SD1">Table S13</xref>). Enrichment analysis of the gene expression trajectory genes identified enrichment in cell signalling pathways, insulin response, cholesterol and lipid metabolism, inflammation, haematopoiesis and blood cell differentiation, and others (<xref ref-type="supplementary-material" rid="SD1">Table S14</xref>).</p><p id="P18">Replication of the differential gene expression results was pursued in two external datasets. First, we used data from the GOTO lifestyle intervention study in 85 individuals, which includes blood gene expression at the fasting state and 30m after a standardized nutrient challenge, both before and after a combined lifestyle intervention<sup><xref ref-type="bibr" rid="R14">14</xref></sup>. We replicated 10 out of 24 (42%) PREDICT gene expression signals in the combined male and female sample from GOTO prior to intervention, at Bonferroni correction (adj. <italic>p</italic> &lt; 0.05; <xref ref-type="supplementary-material" rid="SD1">Table S15A</xref>). Eight genes showed the same direction of effect in GOTO at 30m as in the PREDICT 30m and 4h data postprandially, including <italic>CPT1A</italic> (30m), <italic>SLC25A20</italic> (30m), <italic>AGPAT4</italic> (30m) and <italic>PER1</italic> (30m, 4h) (<xref ref-type="fig" rid="F3">Figure 3C</xref> and <xref ref-type="supplementary-material" rid="SD2">Figure S11</xref>), which are the peak signals from postprandial gene expression trajectory analyses. Eight of the 10 genes replicated in the GOTO combined analysis were also identified in the GOTO females alone (<xref ref-type="supplementary-material" rid="SD1">Table S15B</xref>), and 6 were identified post-exercise intervention as well (<italic>PER1, AGPAT4, DDIT4, SQLE, C15orf39</italic> and <italic>SMAP2</italic>). Other genes with signals replicated post-intervention in GOTO were <italic>ACAA2, FKBP5</italic> and <italic>CCND3</italic> (<xref ref-type="supplementary-material" rid="SD1">Table S15</xref>).</p><p id="P19">We also considered whether our results replicate previous blood gene expression findings from Rask- Andersen et al. (2016) at baseline fasting and 160m postprandially, based on microarray profiling. Of the 945 signals tested, we replicate 17 (adj. <italic>p</italic> &lt; 0.05; <xref ref-type="supplementary-material" rid="SD1">Table S16</xref>). Altogether, <italic>CPT1A, SLC25A20, PER1, ACAA2, DDIT4, C15orf39</italic> and <italic>MYOF</italic> were identified as differentially expressed in blood samples across three independent studies with different test meal challenges – in PREDICT RNA-seq data, in GOTO RNA-seq data from Gehrmann et al<sup><xref ref-type="bibr" rid="R14">14</xref></sup>, and in the microarray expression data from Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup> (<xref ref-type="fig" rid="F3">Figure 3D</xref>).</p></sec><sec id="S7"><title>Coordinated DNA methylation and gene expression postprandial signals</title><p id="P20"><italic>We</italic> found evidence of coordinated changes in DNAm and gene expression over the postprandial state. In the postprandial trajectory results there were 940 genes for which both DNAm and gene expression changes were observed over the postprandial state at nominal significance (<xref ref-type="supplementary-material" rid="SD2">Figure S12A</xref>). This corresponds to 52% and 6% of all differentially expressed and methylated genes at nominal significance (<italic>p</italic> &lt; 0.05) postprandially, respectively. Genes that exhibit coordinated DNAm and expression changes included previously reported <italic>ABCG1, DAGLA, ACSL6</italic> and <italic>NTRK1</italic> (<xref ref-type="supplementary-material" rid="SD1">Table S17A</xref>). Similarly, comparison of 4h meta-analysis DNAm results and gene expression results identified 907 genes that harbour both sets of signals at nominal significance (<xref ref-type="supplementary-material" rid="SD2">Figure S12B</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S17B</xref>). Gene ontology and pathway enrichment analysis of these shared sets of genes showed enrichment for metabolic pathways, inflammation, haematopoiesis and neurotransmission among the DNAm and expression targets (FDR = 25%, <xref ref-type="supplementary-material" rid="SD1">Table S18</xref>).</p><p id="P21">To further explore the extent of shared postprandial signals, we focused on the previously identified 24 genes with differential expression postprandially (<xref ref-type="fig" rid="F3">Figure 3A</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S12</xref>). We carried out expression quantitative trait methylation (eQTM) analyses of the 24 expression signals of these genes and their DNAm levels at fasting baseline, 30m and 4h. Overall, regional DNAm-expression associations identified eQTMs for 88% of genes at nominal significance (<italic>i.e.:</italic> 21 of 24 genes with at least one DNAm probe associated with expression with <italic>p</italic> &lt; 0.05, <xref ref-type="supplementary-material" rid="SD2">Figure S13</xref>). Evidence for eQTMs was observed in the peak postprandial expression signals <italic>CPT1A, SLC25A20</italic> and <italic>AGPAT4.</italic> Co-methylation patterns were also observed across multiple CpGs in genes such as the stress response mediator and mTOR inhibitor<sup><xref ref-type="bibr" rid="R36">36</xref></sup> <italic>DDIT4</italic> and insulin and inflammation-response enhancer-binding transcription factor<sup><xref ref-type="bibr" rid="R37">37</xref></sup> <italic>CEBPD,</italic> where neighbouring co-methylated probes showed the same direction of association with gene expression levels (<xref ref-type="supplementary-material" rid="SD2">Figure S14</xref>).</p></sec></sec><sec id="S8"><title>Genetic regulation of postprandial DNA methylation and gene expression</title><p id="P22">Genetic variability can have substantial effects on DNAm levels. Using data from the MeQTL EPIC Database<sup><xref ref-type="bibr" rid="R38">38</xref></sup> we found cis-methylation quantitative trait loci (cis-meQTLs) for 64 (49.6%) of postprandial DNAm signals, including in <italic>PDE9A, GPT2, DAGLA, A4GALT</italic> and <italic>ABCC1</italic> (<xref ref-type="supplementary-material" rid="SD2">Figure S15A</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S19</xref>). Likewise, genetic variation can modulate the expression of genes and, using data from the eQTLGen phase I<sup><xref ref-type="bibr" rid="R39">39</xref></sup> database, we identified cis- and trans-expression quantitative trait loci (cis- and trans-eQTLs) for 22 and 18 (92% and 75%) of our gene expression signals (<xref ref-type="supplementary-material" rid="SD2">Figure S15B-C</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S20</xref>), respectively, including for <italic>CPT1A, SLC25A20, AGPAT4, ACAA2, ADAP2, DDIT4</italic> and <italic>SQLE.</italic> The circadian rhythm regulator <italic>PER1</italic> did not have significant eQTLs in eQTLGen phase I<sup><xref ref-type="bibr" rid="R39">39</xref></sup>, but had one expression quantitative trait methylation locus (eQTM) in the BIOS database (<xref ref-type="supplementary-material" rid="SD1">Table S21</xref>). Overall, 10 (41%) of our main gene expression signals had eQTMs (<xref ref-type="supplementary-material" rid="SD2">Figure S15D</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S21</xref>), but none of the postprandial DNAm signals that were previously identified as eQTMs in BIOS.</p><p id="P23">We next sought to identify genetic variants that may affect the postprandial molecular trajectories detected. We searched for genetic regulation of DNAm at the 129 unique DMPs (in 95 unique genes) from postprandial 4h meta-analysis and trajectory signals (<xref ref-type="supplementary-material" rid="SD1">Table S1 and Table S6</xref>), and for genetic regulation of 24 genes with postprandial expression changes (<xref ref-type="supplementary-material" rid="SD1">Table S12</xref>). Using public data from the MeQTL EPIC Database<sup><xref ref-type="bibr" rid="R38">38</xref></sup> and eQTLGen phase I<sup><xref ref-type="bibr" rid="R39">39</xref></sup> database we identified the same variants acting as cis-meQTL and cis-eQTL for 19 genes. To explore potential links between DNAm and expression, we performed genetic colocalization analysis. We observed strong evidence for a common causal genetic variant for two CpG-gene pairs, for cg00118229–PDE9A (P(H4) &gt; 0.98) occurring through rs2839581 (chr21:44,158,405) (<xref ref-type="supplementary-material" rid="SD2">Figure S16A</xref>), and for cg14880584–GPT2 (P(H4) &gt; 0.97) occurring through rs72812428 (chr16:46,906,797) (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Another CpG-gene pair, cg17656260–ZNF790 (P(H4) &gt; 0.89), was identified through colocalization, but with a credible set of 17 causal SNPs thus violating the assumption of a single causal variant and was excluded from our results. Sensitivity analysis with varying prior probabilities for cg00118229–<italic>PDE9A</italic> and cg14880584-<italic>GPT2</italic> validated our main results for these CpG-gene pairs (<xref ref-type="supplementary-material" rid="SD2">Figure S17</xref>). Overall, we observe evidence for genetic predisposition for coordinated DNAm and expression changes in <italic>PDE9A,</italic> which is implicated in lipolysis, obesity and heart disease<sup><xref ref-type="bibr" rid="R40">40</xref>–<xref ref-type="bibr" rid="R42">42</xref></sup>, and in <italic>GPT2</italic>, an enzyme that generates pyruvate during gluconeogenesis<sup><xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R43">43</xref></sup>. Both of these genes exhibit significant changes in DNAm levels postprandially (<xref ref-type="fig" rid="F2">Figure 2</xref>; <xref ref-type="supplementary-material" rid="SD1">Tables S1 and S6</xref>), for example, DNAm levels in <italic>GPT2</italic> showed hypermethylation at 30m and 4h after test meal (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Therefore, the underlying genetic effects may potentially also affect the magnitude of the postprandial molecular changes observed at <italic>PDE9A</italic> and <italic>GPT2. We</italic> also observed that the genes identified from our postprandial DNAm and expression analyses (95 genes from DNAm, and 24 genes from expression analyses) harboured genetic variants that were previously identified as GWAS signals for BMI, type 2 diabetes, cholesterol levels, C-reactive protein and blood cell counts (<xref ref-type="supplementary-material" rid="SD1">Table S22</xref>)<sup><xref ref-type="bibr" rid="R44">44</xref></sup>.</p></sec><sec id="S9"><title>DNA methylation signals of postprandial plasma glucose and triglyceride levels</title><p id="P24">The postprandial state is characterised by fast rise of plasma glucose levels within 2h after meal intake, and steady rise in blood triglycerides that peaks at 3–6h after a meal (<xref ref-type="fig" rid="F1">Figure 1</xref>). Here, we link baseline and postprandial DNAm profiles to intra-individual variation in the glucose and triglycerides trajectory after a meal. We investigate if postprandial DNAm levels track inter-individual differences in the postprandial trajectories and concentrations of plasma glucose and triglycerides in females from PREDICT. We also explore if baseline DNAm levels are predictive of the postprandial metabolic response and whether baseline health can impact DNAm trajectories.</p><sec id="S10"><title>Postprandial DNA methylation and expression associations with plasma glucose and triglycerides</title><p id="P25">Firstly, we focused on longitudinal analyses to associate the DNAm trajectory over fasting, 30m and 4h to specific phenotypes postprandially. We observed that postprandial DNAm levels were associated with the 4h incremental area under the curve (iAUC) for triglycerides at 3 CpG sites: cg05086789 in the body of <italic>LOC387647</italic>, cg24013618 in the body of <italic>GAK</italic>, and cg21318603 in the body of <italic>PRPSAP2</italic> (<xref ref-type="fig" rid="F5">Figure 5A</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S23</xref>: FDR = 5%). <italic>PRPSAP2</italic> is a candidate gene for metabolic syndrome<sup><xref ref-type="bibr" rid="R45">45</xref></sup>, and its expression was also significantly associated with the overall triglycerides 4h peak rise in our data (<xref ref-type="supplementary-material" rid="SD1">Table S24</xref>: FDR = 5%). Specifically, cg21318603 was hypomethylated, while <italic>PRPSAP2</italic> was over-expressed with higher triglycerides postprandially (<xref ref-type="fig" rid="F5">Figure 5B</xref>).</p><p id="P26">We also carried out cross-sectional analyses linking DNAm changes to phenotype levels at specific postprandial time-points. We observed that DNAm at 30m postprandially was associated with 30m glucose, and that DNAm at 4h postprandially was most associated with postprandial lipid levels. Specifically, DNAm at 4h was associated with the concentration of triglycerides at 4h and their overall 4h peak rise at 7 DNAm signals: cg09661503 (<italic>SLC6A7</italic>), cg12898632 (<italic>NCKAP5</italic>), cg24595261 (<italic>RAB32</italic>), cg08643928 (<italic>RALGPS2</italic>), cg08669361 (<italic>SFRS18</italic>), cg00712898 (<italic>PRPF38B</italic>) and cg01312316 (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S23</xref>). Cg24595261, which was associated with triglycerides concentration at 4h, is in the extended promoter of <italic>RAB32.</italic> This gene is thought to play a role in lipid storage<sup><xref ref-type="bibr" rid="R46">46</xref></sup>, and we also detected its expression trajectory to be associated with triglycerides 4h peak rise (<xref ref-type="fig" rid="F4">Figure 4B</xref> and <xref ref-type="supplementary-material" rid="SD1">Tables S23 and S24</xref>). Cg08643928, cg08669361 and cg00712898 are in the 5’UTR region of <italic>RALGPS2, SFRS18</italic> and <italic>PRPF38B.</italic> The expression of <italic>RALGPS2</italic> has been linked to cardiovascular disease<sup><xref ref-type="bibr" rid="R47">47</xref></sup>, <italic>SFRS18</italic> plays a role in fat deposition<sup><xref ref-type="bibr" rid="R48">48</xref></sup> and <italic>PRPF38B</italic> has been found to be hypermethylated in female offspring exposed to maternal high saturated fat diet<sup><xref ref-type="bibr" rid="R49">49</xref></sup>. In our study <italic>PRPF38B</italic> was hypermethylated with the rise of blood triglycerides after meal (<xref ref-type="supplementary-material" rid="SD1">Table S23</xref>).</p><p id="P27">In contrast, at 30m DNAm signals captured mostly differences in glucose concentration (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S23</xref>). Four DMPs were identified for glucose concentration at 30m, including cg16452565 in the body of <italic>AGAP1</italic> and cg02920363 in the body of <italic>RCN2</italic>. Differential DNAm in <italic>AGAP1</italic> was previously linked to high-sugar/high-fat diet feeding<sup><xref ref-type="bibr" rid="R50">50</xref></sup> and <italic>RCN2</italic> mediates arterial calcification in hypertension and diabetes<sup><xref ref-type="bibr" rid="R51">51</xref></sup>. Both of these genes were also identified in the gene expression results, linked to inter-individual differences in the glucose iAUC (<xref ref-type="supplementary-material" rid="SD1">Table S24</xref>). At 30m only one CpG site – cg05419671 – was associated with triglyceride levels, while at 4h postprandially 3 CpG signals were still observed to be associated with postprandial measures of glucose (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S23</xref>).</p></sec><sec id="S11"><title>Baseline DNA methylation signals of postprandial glucose and triglycerides trajectories</title><p id="P28">We also tested whether baseline DNAm levels could be predictive of the postprandial metabolic response. DNAm at fasting baseline at cg05399036 (<italic>FOXP1</italic>) and cg07321681 (<italic>CEP55</italic>) was associated with the postprandial level of glucose at 30m and the overall glucose 2h peak rise, respectively (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S23</xref>). <italic>FOXP1</italic> controls systemic glucose homeostasis by upregulating glucose uptake in adipo- and myocytes and shutting-off glucogenesis in hepatic cells<sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>, while <italic>CEP55</italic> is sensitive to glucose concentration and regulates glucose metabolism via the Akt/mTOR pathway<sup><xref ref-type="bibr" rid="R54">54</xref></sup>. <italic>FOXP1</italic> itself can be regulated by PI3K/Akt/mTOR and is newly implicated in the pathogenesis of diabetes<sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>. Here, hypomethylation of cg05399036 and cg07321681, located in 5’UTR and TSS1500 of the <italic>FOXP1</italic> and <italic>CEP55</italic> genes, respectively, was predictive of higher glucose postprandially (<xref ref-type="fig" rid="F5">Figure 5C</xref>). We did not find an association between the expression of these genes and postprandial glucose levels, but we observe an association between <italic>FOXP1</italic> expression levels and postprandial triglyceride levels.</p><p id="P29">Previous work by Lai et. al<sup><xref ref-type="bibr" rid="R5">5</xref></sup> identified baseline DNAm levels at 5 genes – <italic>LPP, CPT1A, APOA5, SREBF1,</italic> and <italic>ABCG1</italic> – to be associated with postprandial levels of blood triglycerides in the GOLDN cohort. While we were unable to identify epigenome-wide DNAm associations for triglycerides at fasting baseline, we replicated some of Lai et. al.’s signals postprandially, specifically the hypomethylation of cg17058475 and cg09737197 in the 5’UTR region of <italic>CPT1A</italic> (<xref ref-type="supplementary-material" rid="SD1">Table S25</xref>). After multiple testing correction, cg17058475 hypomethylation was associated with the fasting levels and overall trajectory of triglycerides in blood (<italic>b</italic> = -0.376 ± 0.118, <italic>p</italic> = 8.96E-04 and <italic>b</italic> = -0.926 ± 0.205, <italic>p =</italic> 4.46E-06, respectively), and hypomethylation of cg09737197 at 30m was associated with the triglycerides 4h peak rise (<italic>b =</italic> -0.231 ± 0.078, <italic>p =</italic> 5.18E-03) (<xref ref-type="fig" rid="F5">Figure 5D</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S25</xref>). Other associations were also detected at nominal significance, including for cg00574958 (<italic>CPT1A</italic>) and cg11024682 in the body of the <italic>SREBF1</italic> gene (<xref ref-type="supplementary-material" rid="SD1">Table S25</xref>). In our data cg11024682 was hypermethylated, like in the GOLDN cohort, at 30m and associated with overall triglycerides 4h iAUC (<italic>b =</italic> 4.20E-04 ± 1.96E-04, <italic>p =</italic> 0.03).</p><p id="P30">Variation in human metabolic responses to food is associated with aging, where older individuals are more likely to have unfavourable glycemic<sup><xref ref-type="bibr" rid="R55">55</xref>,<xref ref-type="bibr" rid="R56">56</xref></sup> and lipemic<sup><xref ref-type="bibr" rid="R57">57</xref></sup> responses. Individuals can also be epigenetically older than their chronological age and epigenetic age acceleration (EAA) has been associated with unfavourable health outcomes and individual responses to lifestyle interventions. As such, we explored whether the participant’s EAA at fasting baseline was associated with their postprandial metabolic signature in PREDICT. EAA can be derived using different epigenetic clocks. We tested six epigenetic ageing measures, the original Horvath<sup><xref ref-type="bibr" rid="R58">58</xref></sup> and Hannum<sup><xref ref-type="bibr" rid="R59">59</xref></sup> clocks, which measure accelerated aging based on different sets of CpGs, PhenoAge<sup><xref ref-type="bibr" rid="R60">60</xref></sup>, which measures healthspan and morbidity, GrimAge<sup><xref ref-type="bibr" rid="R61">61</xref></sup> and GrimAge 2<sup><xref ref-type="bibr" rid="R62">62</xref></sup>, which can measure both morbidity and mortality, and Dunedin PACE<sup><xref ref-type="bibr" rid="R63">63</xref></sup>, a more recent measure for pace of aging. We tested associations between the EAA for each of these measures with postprandial levels of glucose and triglycerides, but results were not significant (<xref ref-type="supplementary-material" rid="SD1">Table S24</xref>). Previous research in the GOLDN cohort identified a modest association between Hannum EAA and postprandial triglycerides <sup><xref ref-type="bibr" rid="R64">64</xref></sup>. We observed the same trend of effects for postprandial triglycerides and Hannum EAA in PREDICT (<xref ref-type="supplementary-material" rid="SD1">Table S26</xref>).</p><p id="P31">This section focused on DNAm profiles and DNAm-based molecular markers of aging at fasting baseline and evaluated their link with the postprandial metabolic response. Next, we explored whether health status at baseline relates to the postprandial molecular trajectories.</p></sec><sec id="S12"><title>Baseline phenotype associations with postprandial molecular trajectories</title><p id="P32">To explore whether measures of baseline health can impact the postprandial molecular response, we analysed fasting blood concentrations of glucose and triglycerides at baseline with the postprandial DNAm levels and trajectories. We observed that fasting triglyceride concentrations showed epigenome-wide significant associations with DNAm levels at 4h postprandially at 3 signals, cg16125109, cg18420301 (<italic>STON2</italic>) and cg08582515 (<italic>PLCE1</italic>) (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S23</xref>). Fasting glucose was associated with cg16680046 DNAm levels captured at 4h postprandially as well (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Table S23</xref>). However, these associations were not reflected at the expression level where <italic>STON2 and PLCE1</italic> gene expression trajectories did not associate with baseline phenotype levels in our data (FDR = 5%).</p></sec><sec id="S13"><title>Postprandial molecular changes capture variation in postprandial glucose and triglyceride levels</title><p id="P33">We assessed whether the 4h meta-analysis and postprandial trajectory results for DNAm and expression (<xref ref-type="fig" rid="F2">Figures 2</xref>,<xref ref-type="fig" rid="F3">3</xref>; <xref ref-type="supplementary-material" rid="SD1">Tables S1, S6, S12</xref>) associated with specific postprandial metabolic phenotypes. We observed that over 70% of the 129 unique DMPs from the DNAm 4h meta-analysis and trajectory analyses were also nominally associated with glucose and triglyceride levels in PREDICT (p &lt; 0.05, <xref ref-type="supplementary-material" rid="SD1">Tables S1 and S6</xref>). This included signals cg03403093 in <italic>INPP4A</italic> where DNAm and triglycerides were associated at 4h (<italic>b =</italic> -0.059 ± 0.027, <italic>p =</italic> 0.022), cg26254678 in <italic>DAGLA</italic> where DNAm and triglycerides were linked at both timepoints including at 4h (<italic>b =</italic> 0.062 ± 0.022, <italic>p =</italic> 0.004), and cg07870237 in <italic>ACSL6</italic> where DNAm timepoints were overall associated with glucose peak rise (<italic>b</italic> = -0.041 ± 0.019, <italic>p =</italic> 0.043). Other nominally significant association signals included cg04924511 in <italic>GHRL</italic> and cg27518648 in <italic>ABCG1</italic> where DNAm at 30m was linked to glucose levels both at fasting and 30m after meal (<italic>b =</italic> -0.071 ± 0.030, <italic>p =</italic> 0.018 and <italic>b =</italic> -0.016 ± 0.008, <italic>p =</italic> 0.036, respectively). Nominally significant phenotype associations were also detected with gene expression changes of <italic>INPP4A, ACSL6, GHRLOS</italic> and <italic>ABCG1,</italic> as were levels of some of the main trajectory gene expression signals, such as <italic>PER1, ACAA2, ADAP2, C15orf39, MYOF, POU2F2, SMAP2</italic> and <italic>AGPAT4</italic> (<italic>p</italic> &lt; 0.05, <xref ref-type="supplementary-material" rid="SD1">Table S12</xref>). Overall, we observed that <italic>ABCG1</italic> was hypermethylated at 4h (<xref ref-type="supplementary-material" rid="SD1">Table S1</xref>), under-expressed with the triglycerides 4h peak rise and iAUC (<italic>b =</italic> -0.610 ± 0.120, <italic>p =</italic> 5.87E-04 and <italic>b =</italic> -0.005 ± 0.001, <italic>p =</italic> 0.005, respectively), and linked to blood sugar at 30m. <italic>ABCG1</italic> association with postprandial glucose is in line with evidence that beyond lipid metabolism <italic>ABCG1</italic> participates in the metabolism of sugars by controlling the secretion and activity of insulin<sup><xref ref-type="bibr" rid="R19">19</xref></sup>.</p><p id="P34">Our previous results integrating genetic data into the postprandial DNAm and gene expression trajectories further highlighted two genes, <italic>GPT2</italic> and <italic>PDE9A,</italic> that were under genetic regulation (<xref ref-type="fig" rid="F4">Figure 4A</xref>). Integrating these data with the phenotype results, we observe that the postprandial hypomethylation of cg00118229 (<italic>PDE9A</italic>) at 30m is also negatively associated to triglycerides peak rise (<italic>b =</italic> -0.061 ± 0.026, <italic>p =</italic> 0.029, <xref ref-type="supplementary-material" rid="SD2">Figure S16B</xref>). Similarly, we observed that postprandial hypermethylation of cg14880584 (<italic>GPT2</italic>) and under-expression of <italic>GPT2</italic> at 30m are associated with the inter-individual glucose response after meal (DNAm <italic>b =</italic> 3.32E-04 ± 1.33E-04, <italic>p =</italic> 0.026; and expression <italic>b =</italic> -0.002 ± 6.49E-04, <italic>p =</italic> 0.036) (<xref ref-type="fig" rid="F4">Figure 4B</xref>).</p></sec></sec></sec><sec id="S14" sec-type="discussion"><title>Discussion</title><p id="P35">In this study, we conducted the largest exploration to date of changes in blood-based DNAm and gene expression trajectories during the postprandial state in humans. We profiled blood DNAm and gene expression at fasting, and at 30m and 4h after a meal in 225 participants from two international cohorts, PREDICT and CORDIOPREV. We observed longitudinal changes in the regulation and function of key metabolic genes with implications for cardiometabolic health. We show evidence for links between DNAm and gene expression levels of certain metabolic genes, and baseline and postprandial levels of plasma glucose and triglycerides. Moreover, we identify specific scenarios of genetic regulation of coordinated changes in DNAm and gene expression, that may affect the postprandial metabolic response. The identified molecular signals could represent a response to food intake that may in turn contribute to disease risk such as postprandial rise in glucose and triglyceride levels, or alternatively these signals may reflect an adaptive response to postprandial metabolism in the organism.</p><p id="P36">The transition from a fasted to a postprandial state represents a major change in physiology that tests nutritional phenotypic flexibility of humans<sup><xref ref-type="bibr" rid="R65">65</xref></sup>. The metabolic processes associated with digestion and absorption of food, specifically postprandial hyperglycemia and hypertriglyceridemia, have emerged as independent risk factors for type 2 diabetes and cardiovascular diseases such as atherosclerosis and myocardial infarction<sup><xref ref-type="bibr" rid="R65">65</xref>,<xref ref-type="bibr" rid="R66">66</xref></sup>. Indeed, postprandial glucose and lipids are stronger predictors of cardiovascular events than their fasted levels<sup><xref ref-type="bibr" rid="R67">67</xref>–<xref ref-type="bibr" rid="R69">69</xref></sup>. Given the high inter-individual variability in postprandial metabolic response<sup><xref ref-type="bibr" rid="R1">1</xref></sup>, we aimed to characterise molecular mechanisms underlying this variability by profiling DNAm and gene expression levels at baseline and at postprandial time-points associated with the glycemic (30m) and lipemic (4h) metabolic responses. We studied participants in mid-life from two cohorts, including a sample of 104 healthy female individuals from the UK PREDICT study who were fed a high fat high carbohydrate test meal, along with a sample of 121 male diabetic coronary heart disease patients from the Spanish CORDIOPREV study who were fed a high fat meal. These differences in cohort profiles and test meal challenges highlight the robust nature of the observed epigenetic results postprandially at 4 hours, which typically corresponds to peak lipemia phase.</p><p id="P37">We observed over a hundred DNAm signals at 4h postprandially in meta-analysis of the PREDICT and CORDIOPREV studies. The majority and most-associated DNAm signals were in genes previously linked to obesity and type 2 diabetes, and lipid metabolism. These included the cholesterol efflux pump <italic>ABCG1</italic> and <italic>ASIP</italic> genes, where <italic>ASIP</italic> was the first obesity gene to be characterised decades ago<sup><xref ref-type="bibr" rid="R24">24</xref></sup> and <italic>ABCG1</italic> has many roles in metabolic health, including controlling the secretion and activity of insulin and lipoprotein lipase<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. DNAm of <italic>ABCG1</italic> at various CpG sites has been inversely associated with HDL cholesterol and directly associated with triglycerides in blood<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R19">19</xref></sup>. Here we report DNAm at a novel CpG site in <italic>ABCG1</italic> (cg27518648) where DNAm is also directly associated with postprandial lipemia at 4h. We also observed increased DNAm of <italic>GHRL</italic> promoter region (cg04924511) at 4h. The <italic>GHRL</italic> gene is responsible for synthesizing the preproghrelin precursor to ghrelin which is a hormone that acts primarily on the brain to stimulate eating and has secondary functions in the regulation of blood sugar and cellular homeostasis<sup><xref ref-type="bibr" rid="R22">22</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup>. A previous postprandial DNAm study<sup><xref ref-type="bibr" rid="R6">6</xref></sup> also explored <italic>GHRL</italic> in candidate analysis and found cg04924511 to be hypermethylated at 160m after meal intake after adjusting for cell composition, but the effect was not nominally significant. Neither we nor previous work observed a link between DNAm at cg04924511 and <italic>GHRL</italic> overall expression levels, but finer resolution expression analyses such as alternative splicing may need to be carried out to assess its full regulatory potential.</p><p id="P38">The additional sample time-points in PREDICT allowed us to dissect the postprandial epigenetic trajectories by also considering effects at peak glycemia (30min), as well as extending to gene expression trajectories in a sample’s subset. Postprandial trajectory analyses captured DNAm and expression changes in genes implicated in metabolism (<italic>CAMTA1, CTP1A</italic> and <italic>SLC25A20</italic>), inflammation (<italic>FKBP5, PDE4D</italic> and <italic>CEBPD),</italic> stress response (<italic>CAMTA1, FKBP5</italic>), and circadian rhythm (<italic>PER1</italic>). <italic>PER1</italic>, in addition to being a core component of the circadian clock, regulates blood pressure<sup><xref ref-type="bibr" rid="R70">70</xref></sup> and is over-expressed during fasting-induced oxidative stress in the mitochondria<sup><xref ref-type="bibr" rid="R35">35</xref></sup>. In our case, <italic>PER1</italic> was under-expressed postprandially at 30m and 4h in comparison to fasting baseline, which has implications for effects of food intake as a regulator of circadian rhythm.</p><p id="P39"><italic>CPT1A</italic> and <italic>SLC25A20</italic> are both key components of lipid metabolism in mitochondrial fatty acid oxidation<sup><xref ref-type="bibr" rid="R71">71</xref></sup>, and ACAA2 catalyses the last step of the fatty acid beta oxidation in the mitochondria <sup><xref ref-type="bibr" rid="R72">72</xref></sup>. The rate of fatty acid oxidation is highest during fasting<sup><xref ref-type="bibr" rid="R73">73</xref></sup>, therefore <italic>CPT1A</italic> and <italic>SLC25A20,</italic> which were both under-expressed postprandially in our study, are likely downregulated after meal intake. Further lipid metabolism genes among the signals include <italic>AGPAT4,</italic> which catalyses a precursor to triacylglycerol<sup><xref ref-type="bibr" rid="R74">74</xref></sup> and <italic>SQLE,</italic> which is the first oxygenation enzyme in cholesterol biosynthesis<sup><xref ref-type="bibr" rid="R75">75</xref></sup>. On the other hand, <italic>PDE4D</italic> is key in the degradation of the immunoregulatory cyclic adenosine monophosphate (cAMP) molecule<sup><xref ref-type="bibr" rid="R76">76</xref></sup>, while <italic>FKBP5</italic> binds directly to co-chaperones of the steroid receptor complex in response to stress and is under the influence of both diet-induced obesity and epigenetic regulation<sup><xref ref-type="bibr" rid="R77">77</xref>,<xref ref-type="bibr" rid="R78">78</xref></sup>. <italic>CAMTA1</italic> is a transcription factor that also responds to stress and is involved in insulin production and secretion<sup><xref ref-type="bibr" rid="R29">29</xref></sup> with potential modest impact in type 2 diabetes<sup><xref ref-type="bibr" rid="R79">79</xref>,<xref ref-type="bibr" rid="R80">80</xref></sup>. Cg23021268 in <italic>CAMTA1</italic> was the most associated postprandial DNAm signal in PREDICT and was hypomethylated over the glycemic response to food at 30m. <italic>CAMTA1</italic> has been found to be hypermethylated after <italic>in utero</italic> exposure to a high-fat diet<sup><xref ref-type="bibr" rid="R81">81</xref></sup>, and in line with this in our results cg23021268 DNAm levels increased from 30m over the course of the lipemic response at 4h. Furthermore, multiple genes exhibited coordinated changes in postprandial DNAm and gene expression levels, including key lipid metabolism genes <italic>ABCG1, CPT1A,</italic> as well as <italic>SLC25A20, DDIT4,</italic> and others.</p><p id="P40">The results from postprandial 4h meta-analysis and DNAm and expression trajectories in PREDICT females alone identified 119 unique genes where molecular genomic changes were identified postprandially. The genes were enriched for pathways involved in fat metabolism, inflammation, haematopoiesis and neurotransmission. We successfully replicated a proportion of these DNAm and gene expression postprandial trajectory results in two independent studies <sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R14">14</xref></sup>. The replication studies were carried out in samples from different populations and at different age ranges, with different test meal challenges, and in males only or mixed male and female samples who were sampled at different time-points postprandially, and in some cases profiled using different molecular profiling technologies. These differences highlight the robust nature of the replicated postprandial blood changes. The first replication study by Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup> analysed whole blood DNAm using Illumina Infinium HumanMethylation450 BeadChip and microarray gene expression in 26 healthy men before and 160m after a standardized mixed breakfast of whole wheat, fruit and cheese. The second replication study by GOTO<sup><xref ref-type="bibr" rid="R14">14</xref></sup> collected transcriptomic data from 85 healthy older participants before and 30m after a standardized meal replacement shake. In our study we replicated 15% of DMPs reported by Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup> and identified 7 genes with postprandial gene expression changes across PREDICT, Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup> and the GOTO<sup><xref ref-type="bibr" rid="R14">14</xref></sup> studies: <italic>CPT1A, SLC25A20, PER1, ACAA2, DDIT4, C15orf39</italic> and <italic>MYOF.</italic> These results demonstrate the robust nature of postprandial gene expression changes at these seven genes involved in lipid metabolism, circadian rhythm and cellular responses to stress and inflammation.</p><p id="P41">We next observed associations between some of the postprandial DNAm and expression signals with postprandial levels of glucose and triglycerides. Cross-sectionally, DNAm at 30m and 4h was most strongly associated with glucose and triglyceride levels, respectively. This was expected since glucose peaks first, and chylomicron triglycerides and VLDL triglycerides only peak at 3–4h or 4–6h after meal<sup><xref ref-type="bibr" rid="R82">82</xref></sup>, respectively. The genes that harbour the signals that underlie these associations included <italic>RAB32</italic> (linked to lipid storage<sup><xref ref-type="bibr" rid="R46">46</xref></sup>, also detected with gene expression), <italic>RALGPS2</italic> (linked to cardiovascular disease<sup><xref ref-type="bibr" rid="R47">47</xref></sup>), <italic>SFRS18</italic> (fat deposition<sup><xref ref-type="bibr" rid="R48">48</xref></sup>), and <italic>PRPF38B</italic> (linked to high saturated fat diet<sup><xref ref-type="bibr" rid="R49">49</xref></sup>). Longitudinally, the postprandial DNAm trajectories of several genes including <italic>PRPSAP2</italic> (metabolic syndrome<sup><xref ref-type="bibr" rid="R45">45</xref></sup>) associated with the postprandial triglyceride levels, measured by the iAUC. In contrast, baseline levels of DNAm were associated with postprandial levels of glucose, rather than triglycerides. Fasting DNAm levels in two genes, <italic>FOXP1</italic> (controls systemic glucose homeostasis <sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>) and <italic>CEP55</italic> (regulates glucose metabolism via the Akt/mTOR pathway<sup><xref ref-type="bibr" rid="R54">54</xref></sup>) were linked to postprandial glucose with implication for glucose homeostasis and metabolism. This result is intriguing as it has implications for the potential of fasting DNAm levels as a baseline prediction tool of the postprandial glucose peak, which is a risk factor for cardiometabolic health. Lack of similar datasets limited our ability to pursue replication of our postprandial glucose and triglyceride DNAm associations, but we explored how previous findings replicated in our data. Specifically, the GOLDN study profiled fasting baseline DNAm levels in CD4+ T-cells in 979 subjects of European descent, and identified associations with postprandial lipid levels after a high fat meal<sup><xref ref-type="bibr" rid="R5">5</xref></sup> in 5 genes, <italic>CPT1A, ABCG1, SREBF1, LPP</italic> and <italic>APOA5. We</italic> replicated triglyceride associations with DNAm at cg17058475 and cg09737197 in <italic>CPT1A</italic> after multiple testing correction, and at cg11024682 in <italic>SREBF1</italic> at nominal significance, albeit not at baseline. Particularly, in our data postprandial DNAm in cg09737197 was inversely associated with the triglycerides peak rise, which controls for baseline triglycerides by subtracting the fasting levels from their 4h peak. Furthermore, signals in <italic>ABCG1</italic> and <italic>LPP</italic> were hypermethylated with triglycerides postprandially in the GOLDN dataset, and while we did not replicate these, we observed that <italic>ABCG1</italic> and <italic>LPP</italic> were under-expressed with triglycerides, particularly with stronger triglycerides peak rises (<italic>p</italic> &lt; 0.001) (<xref ref-type="supplementary-material" rid="SD1">Table S27</xref>).</p><p id="P42">The 119 unique genes identified from postprandial changes in DNAm and expression were enriched for pathways related to fat metabolism, inflammation, haematopoiesis and neurotransmission. Integration of these results with the EWAS Catalog, identified enrichment of previously published associations of these CpGs with traits such as BMI, C-reactive protein and blood cell lineage-specific proteins. Using publicly available databases we assessed whether genetic background may impact the identified postprandial DNAm and expression signals. We identified cis-meQTLs and cis-eQTLs for 49.6% and 92% of our epigenetic and expression signals (<xref ref-type="supplementary-material" rid="SD1">Tables S19 and S20</xref>), respectively. In the GWAS Catalog, multiple genetic variants within the genes identified in our study were previously associated with traits such as type 2 diabetes, cholesterol, and also BMI, C-reactive protein and blood cell counts. Overall, there is strong prior evidence that human genetics plays a role in determining the levels of DNAm and expression of genes. Furthermore, our colocalization analyses found evidence for shared genetic regulation of DNAm and gene expression levels at two genes with postprandial DNAm and expression changes, <italic>PDE9A</italic> (linked to lipolysis, obesity and heart disease<sup><xref ref-type="bibr" rid="R40">40</xref>–<xref ref-type="bibr" rid="R42">42</xref></sup>) and gluconeogenesis<sup><xref ref-type="bibr" rid="R26">26</xref>,<xref ref-type="bibr" rid="R43">43</xref></sup> gene <italic>GPT2</italic>. The signal in gluconeogenesis gene <italic>GPT2</italic> was hypermethylated postprandially, and at 30m its hypermethylation and under-expression was also associated with postprandial glucose response. Taken together these results provide specific examples of potential genetic regulation of the postprandial molecular genetic response that may be mediated <italic>via</italic> DNAm and gene expression effects, and in the case of <italic>GPT2</italic> strongly relate to postprandial glucose levels.</p><p id="P43">We considered biological scenarios that may explain the observed changes in postprandial DNAm levels as early as 30m after meal intake. First, we considered mammalian DNA methyltransferase kinetics. <italic>In vitro</italic> experiments by Adam et. al <sup><xref ref-type="bibr" rid="R83">83</xref></sup> showed that murine DNMT1 can methylate up to 70% of DNA within the first 30m of incubation with hemimethylated DNA substrate. The genomic context of CpG sites matters for timing of DNAm and Adam et. al found that demethylation is favoured at sites where DNMT1 has less affinity for the DNA molecule<sup><xref ref-type="bibr" rid="R83">83</xref></sup>. Timing of demethylation has been further explored by Ravichandran et al.<sup><xref ref-type="bibr" rid="R84">84</xref></sup> where authors showed that mammalian TET3 can demethylate up to half of CpG sites in the canonical E-box ‘CACGTG’ motif within 30 minutes of <italic>in vitro</italic> incubation. Given the kinetics of mammalian DNA methyltransferase and de-methylation processes, although it is possible that the detected effects represent novel methylation and demethylation events, another plausible scenario is postprandial change in blood cell composition. In line with this, we detected changes in blood cell subtypes following meal intake, most prominent in the proportions of monocytes, granulocytes and natural killer cells (<xref ref-type="supplementary-material" rid="SD2">Figure S4</xref>). Changes in blood cell proportion may be attributed to overproduction of particular cell sub-populations, or sequestration, or changes in activation of specific cell types. Indeed, previous studies have reported changes in postprandial blood cell proportions <sup><xref ref-type="bibr" rid="R6">6</xref></sup> and evidence for postprandial activation of leukocytes<sup><xref ref-type="bibr" rid="R85">85</xref></sup>. For example, in healthy subjects, postprandial studies following fat intake have reported an increase in neutrophil counts around peak postprandial lipemia, as well as increased activation of monocytes and neutrophils<sup><xref ref-type="bibr" rid="R86">86</xref></sup>. A specific example of postprandial leukocyte activation that is likely relevant to our findings is postprandial activation of monocytes, such as lipid-laden monocytes. Khan et al.<sup><xref ref-type="bibr" rid="R86">86</xref></sup> reported that in comparison to controls, obese subjects with metabolic syndrome had both higher fasting levels of lipid-laden foamy monocytes and significant postprandial increase in activation markers on these nonclassical monocytes. Activated monocytes with greater inflammatory and adhesion potential may lead to increased transendothelial migration, contributing to progression of atherosclerosis.</p><p id="P44">One of the main limitations of our study is that analyses were conducted in blood, a heterogeneous collection of cells. DNAm in PREDICT was generated for whole blood samples, while in CORDIOPREV the polymorphonuclear leukocyte blood fraction was extracted. Therefore, the meta-analysis signals that we identify in postprandial lipemia are relevant only to polymorphonuclear leukocytes and changes in these cells. Previous work by Rask-Andersen et al. <sup><xref ref-type="bibr" rid="R6">6</xref></sup> highlighted the importance of accounting for changes in blood cell composition when considering postprandial DNAm. We correct for blood cell type heterogeneity by including estimates of blood cell proportions as covariates in the linear associations. However, the level of resolution of the estimated blood cell types is not high, for example, our data do not differentiate between DNAm signals in monocytes and in lipid-laden foamy monocytes. We attempted to explore this heterogeneity further by profiling DNAm in a small sample of matched CD4+ T-cells and whole blood, where we see overall some consistency in DNAm levels, with 41% of tested signals showed the same direction of effects. However, our study design did not target additional blood cell subtypes, such as monocytes, granulocytes and natural killer cells, which should be explored in future studies of postprandial molecular genomic trajectories.</p><p id="P45">Circadian rhythm and seasons can affect human metabolism<sup><xref ref-type="bibr" rid="R87">87</xref>,<xref ref-type="bibr" rid="R88">88</xref></sup> and thus may impact postprandial responses to food. To this end, we accounted for seasonality as a covariate in the linear association models. All participants in PREDICT and CORDIOPREV had the test meal in the morning after an overnight fast, therefore minimising potential effects of circadian rhythm variability on DNAm levels. To further explore potential effects of circadian rhythm, we interrogated a previously published dataset of CpGs with reported circadian oscillation in human DNAm<sup><xref ref-type="bibr" rid="R33">33</xref></sup> but we did not find evidence for a major effect of time of day. Another limitation is that many analyses in PREDICT included only females and it is highly likely that females and males yield different DNAm and expression responses to a food challenge, as previously observed for gene expression<sup><xref ref-type="bibr" rid="R14">14</xref></sup>. Because the CORDIOPREV sample was male, our PREDICT-CORDIOPREV meta-analysis identified sex-shared effects. Sex-specific analyses were challenging to undertake in our study due to confounding with differences in phenotypes (the PREDICT sample was composed of healthy middle-aged British females while the CORDIOPREV study was composed of middle-aged Spanish coronary heart disease patients) and test meal challenges (PREDICT meal was high in carbohydrates and fat while the CORDIOPREV meal was high in fat alone, with different food composition). Lastly, the CORDIOPREV samples were available only fasting baseline and 4h, therefore, giving us greater power to identify DNAm signals associated postprandially at 4h during peak lipemia, than during peak glycemia. Replication of the gene expression results from PREDICT in the GOTO study also suffered from similar limitations due to differences in study population, study design, meal composition and timepoints availability. Due to these reasons, interpreting the directions of effect of signals postprandially across studies was challenging. Future postprandial analyses of DNAm and gene expression will also benefit from time- matched larger replication samples to ascertain impact of food response in cardiovascular disease.</p></sec><sec id="S15" sec-type="conclusions"><title>Conclusion</title><p id="P46">Postprandial changes in blood DNAm and gene expression were observed at key metabolic genes postprandially, from baseline fasting to 30m and 4h after meal intake. Some of the signals reflect the inter-individual variation observed in blood glucose and triglyceride levels after a meal, with potential to act as either mediators of, or signals reflecting postprandial metabolism processes. Overall our findings identify postprandial molecular genetic changes in genes related to metabolism, inflammation, circadian rhythm and other processes, and emphasize the need for future studies into postprandial molecular changes within specific cell sub-types. The results highlight DNAm as a key regulatory mechanism of gene expression over the human postprandial state, with implications in cardiometabolic health outcomes.</p></sec><sec id="S16" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S17"><title>Study samples</title><p id="P47">In this study we used blood samples from participants recruited in the ZOE PREDICT 1 (PREDICT) <sup><xref ref-type="bibr" rid="R15">15</xref></sup> and CORDIOPREV<sup><xref ref-type="bibr" rid="R16">16</xref></sup> studies. Both studies performed a food challenge on day one of clinical visit and blood samples were extracted after overnight fast, and postprandially after food intake. The PREDICT food challenge aimed to stress the body’s overall metabolic response to food in 1002 healthy middleaged participants from the UK (mean age = 45.6 ± 11.9 years, BMI = 25.6 ± 5.0 kg/m<sup>2</sup>). Participants fasted overnight and following baseline blood draw participants were given breakfast (muffin and milkshake) that was high in carbohydrates and fat (850 kcal from 85g of carbohydrates, 50g of fat and 15g of protein). In addition to fasting, blood was drawn at 15, 30, 60, 120, 180, 240m after test meal for analysis of the postprandial response. The CORDIOPREV food challenge aimed to study the body’s response to dietary fat in 1002 middle-aged coronary disease patients from Spain (mean age = 59.5 ± 0.2 years, BMI = 31.1 ± 0.1 kg/m<sup>2</sup>). A fasting blood sample was taken immediately afterwards the patients ingested a weight-adjusted meal (0.7 g fat and 5 mg cholesterol per kg body weight) with 12% saturated fatty acids (SFAs), 10% polyunsaturated fatty acids, 43% monounsaturated fatty acids, 10% protein and 25% carbohydrates from olive oil, skimmed milk, white bread, cooked egg yolks, and tomatoes. In addition to the fasting sample, blood was extracted every hour during the 4 h after test meal, according to established protocols. Both PREDICT and CORDIOPREV test meals were prepared by nutritionists and volunteers rested and consumed no food for 4h but were allowed to drink water. Here, we used samples collected at fasting and 30m and 4h postprandially in the PREDICT study to explore the DNAm and expression trajectories associated with the glycemic and lipemic responses to food. Additionally, we used blood samples collected at fasting and 4h postprandially in CORDIOPREV to meta-analyse the longitudinal DNAm changes associated with postprandial lipemia in PREDICT and CORDIOPREV.</p></sec><sec id="S18"><title>Extraction and processing of biological data</title><sec id="S19"><title>DNA methylomes</title><p id="P48">DNAm profiles were extracted from 360 whole blood samples collected at 3 timepoints from 120 participants in PREDICT and 292 polymorphonuclear leukocyte blood fraction samples collected at 2 timepoints from 150 diabetic coronary heart disease patients in CORDIOPREV. An additional 30 DNAm profiles were extracted from CD4+ T cell samples collected at 3 timepoints from 10 participants in PREDICT for blood cell type analysis. Genomic DNA was extracted and bisulphite converted using the EZ-96 DNA Methylation Kit (Zymo Research, Orange, CA, USA). Subsequent methylation analysis was performed on an Illumina (San Diego, CA, USA) iScan platform using the Infinium MethylationEPIC BeadChipv1 according to standard protocols provided by Illumina. GenomeStudio software version 2011.1 with Methylation Module version 1.9.0 was used for initial quality control of assay performance and for generation of methylation data export files.</p><p id="P49">DNAm data was processed using R Bioconductor software<sup><xref ref-type="bibr" rid="R89">89</xref></sup> and <xref ref-type="sec" rid="S16">methods</xref> previously described<sup><xref ref-type="bibr" rid="R4">4</xref></sup>. First, samples with median methylated and unmethylated signal ratio &lt; 10.5 were excluded using the <italic>minfi</italic> package<sup><xref ref-type="bibr" rid="R90">90</xref></sup>. Second, background correction, dye bias correction and quantile normalization were performed with the ENmix package <sup><xref ref-type="bibr" rid="R91">91</xref></sup>. Underperforming probes and outlier samples were identified with standard parameters and signals with detP &gt; 0.000001 and nbead &lt; 3 were excluded. DNAm beta values were estimated after applying the Regression on Correlated Probes method<sup><xref ref-type="bibr" rid="R92">92</xref></sup> in ENmix, and subsequently converted to DNAm M-values using the <italic>lumi</italic> package<sup><xref ref-type="bibr" rid="R93">93</xref></sup>. Maximum missingness threshold in samples and probes was 1% and 5%, respectively, and polymorphic or probes that mapped to multiple locations in the genome were removed. A total of 356 and 279 whole blood samples from 120 and 148 participants, and 755,438 and 747,764 autosomal probes, were kept in PREDICT and CORDIOPREV data, respectively. Blood cell proportions of samples were estimated using the Houseman method<sup><xref ref-type="bibr" rid="R94">94</xref></sup> as implemented in Horvath’s DNA Methylation Age Calculator<sup><xref ref-type="bibr" rid="R58">58</xref></sup>.</p></sec><sec id="S20"><title>Transcriptomes</title><p id="P50">Bulk RNA was extracted from 150 whole blood samples collected at 3 timepoints from a subset of 50 female participants in PREDICT. Extractions and RNA sequencing were performed by Novogene (Cambridge, UK) using Illumina’s Novaseq 6000 instrument.</p><p id="P51">Quality control of sequencing reads was performed using FastQC<sup><xref ref-type="bibr" rid="R95">95</xref></sup>. FastQScreen<sup><xref ref-type="bibr" rid="R96">96</xref></sup> was used to assess contamination of samples. Afterwards, paired reads were adaptor and quality trimmed with Trim Galore (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/proiects/trim_galore/">https://www.bioinformatics.babraham.ac.uk/proiects/trim_galore/</ext-link>), which implements trimming with cutadapt<sup><xref ref-type="bibr" rid="R97">97</xref></sup>, with minimum 3 bp adaptor overlap and Phred score of 20. The STAR aligner<sup><xref ref-type="bibr" rid="R98">98</xref></sup> was used to map sequencing reads to the human genome GRCh38 build, with the Y chromosome masked, 2-pass mapping and standard parameters. Alignments were then filtered with SAMtools<sup><xref ref-type="bibr" rid="R99">99</xref></sup> and only uniquely mapped properly paired reads were kept for downstream analyses. Featurecounts<sup><xref ref-type="bibr" rid="R100">100</xref></sup> was used to annotate and quantify genes using the ENSEMBL annotation of the reference genome (version GRCh38.92) and standard parameters. Sample normalisation was performed using the transcripts per million (TPM) method and genes were kept if they were expressed at ≥0.5 TPM in at least 10% of samples. For each gene, TPMs were further rank-based inverse normalised prior to association analyses. All 150 samples from the 50 participants and 23,466 autosomal gene-level transcripts were kept after data processing.</p></sec></sec><sec id="S21"><title>Statistical analyses</title><p id="P52">The PREDICT and CORDIOPREV DNAm samples were 87% female and 84% male, respectively, and we analysed PREDICT females and CODIOPREV males alone in this study. Altogether, and after excluding samples missing the covariates that we integrated into the models, we analysed whole blood DNAm in 308 samples from 104 PREDICT females, 232 samples from 121 CORDIOPREV males, and expression in a time-matched subset of 148 samples from 50 females in PREDICT.</p><sec id="S22"><title>Meta-analysis of PREDICT and CORDIOPREV DNAm signals</title><p id="P53">We used the PREDICT and CORDIOPREV samples to meta-analyse the longitudinal DNAm changes associated with postprandial lipemia at 4h. For this we applied linear mixed-effects models using the lme4 package<sup><xref ref-type="bibr" rid="R101">101</xref></sup> with DNAm M-values as the response to timepoint coded as factor 0/1 for fasting-4h time-point differences. We adjusted models for age, BMI, smoking (using 0 for never smoker, 1 for ex-smoker and 2 for current smoker), estimated blood cell proportions (CD8T, CD4T, NK, B cells, granulocytes and monocytes) and season (coded as 0/1/2/3 for Spring/Summer/Autumn/Winter) as fixed effects, chip, chip position and the participant as random effects, and family and zygosity in PREDICT as random effects as well. METAL<sup><xref ref-type="bibr" rid="R102">102</xref></sup> was used for fixed-effects inverse variance weighted meta-analysis of 746,953 autosomal probes in PREDICT and CORDIOPREV. Results are presented after multiple testing with false discovery rate (FDR) = 5% and filtered for heterogeneity with HetISq &lt; 85% and HetPval ≥ 0.01. Inflation in CORDIOPREV and PREDICT results was 1.3 and 1.1, respectively, which we accepted as maximum reasonable inflation in our analyses considering our limited sample sizes and the overall metabolic changes that can occur after meal. Sensitivity analyses were performed using raw DNAm β-values as opposed to M-values, as well as using the complete sample of mixed female and male participants with all covariates in each cohort (104 females and 16 males in PREDICT; 121 males and 24 females in CORDIOPREV).</p></sec><sec id="S23"><title>Analysis of DNA methylation and expression trajectories in PREDICT</title><p id="P54">For analysis of DNAm and expression trajectories we used the PREDICT sample that contained timepoints at fasting and postprandially at 30m and 4h. For DNAm analysis: DNAm M-values were the response to timepoint coded as factor 0/1/2 for fasting-30m-4h differences in a linear mixed effects model adjusted as immediately above. For expression analysis: gene-level inverse normalised TPMs were the response to timepoint coded as factor 0/1/2 in a linear regression model. The model for expression was adjusted for PC2-12, GC mean and RIN. PC1 was not included in the model since it was correlated with the exposure variable, timepoint. PC2-12 explained 31% of total variance in the data and were correlated with covariates such as age, BMI, smoking, blood cell counts, and technical covariates such as rack. GC mean and RIN were added separately to the model because they were highly correlated with PC1. Separately, we trialled gene expression analysis with a linear mixed effects model adjusted similarly to our DNAm analyses and including the transcriptomic-specific covariates. Results from this model were very inflated (λ = 4.1 vs λ = 1.1 in model with PCs). As such, we present results from the linear model adjusted with PCs first and use the linear mixed effects model results for sensitivity analysis. Post-hoc analysis of timepoints was performed using DNAm M-value and gene expression residuals with pairwise t-tests across the 3 possible groups (0-30m, 0-4h and 30m-4h DNAm). The Holm method was used to correct <italic>p</italic>-values across the groups (adj. <italic>p</italic> &lt; 0.05).</p></sec><sec id="S24"><title>Expression quantitative trait methylation analysis</title><p id="P55">eQTM analyses were carried for the 24 gene expression signals identified from the main gene expression analysis. Coordinated changes at fasting baseline, 30m and 4h were explored across 146 time-matched samples using DNAm M-values as the response variable to residuals of gene expression so that we could adjust DNAm directly in the linear model. Covariates for DNAm were the same as previously, and gene expression residuals reflected normalised expression adjusted for PC2-12, RIN and GC mean. Associations are reported with nominal significance (<italic>p</italic> &lt; 0.05) within target gene. Finally, we inspected gene co-methylation levels and correlation between methylated probes and gene expression and report correlation scores computed using Pearson’s correlation coefficient.</p></sec><sec id="S25"><title>Analysis of DNAm and gene expression links to glucose and triglycerides</title><p id="P56">Genome-wide DNAm and expression associations were performed with postprandial glucose and triglyceride levels in PREDICT (<xref ref-type="supplementary-material" rid="SD1">Table S28</xref>). To track changes over the postprandial phase we used the 2h peak rise and 2h iAUC, and 4h peak rise and 4h iAUC, for plasma glucose and triglycerides, respectively. The peak rise metric, particularly, adjusts for baseline levels by subtracting the fasting glucose and triglyceride levels from their postprandial peak. In addition to this, we tested associations with direct plasma glucose at fasting, 30m and 4h, and triglycerides at fasting and 4h. Blood triglycerides were not profiled at 30m in PREDICT and 30m triglycerides are not associated with postprandial lipemia. Measurement outliers were excluded from the analysis by removing concentration values that were larger or smaller than 3 standard deviations from the mean.</p><p id="P57">First, we tracked the trajectory of DNAm and expression with the trajectory of plasma glucose and triglycerides. For this, we used DNAm and expression at fasting, 30m and 4h like in previous models plus timepoint and the interaction of timepoint and glucose or triglycerides as additional covariates. In expression analyses PC3, and PC7 and PC8, were excluded due to correlation with triglycerides and glucose, respectively. Beyond this analysis, we also used the 3-timepoint epigenetic and transcriptomic data in overall associations with the glucose and trigylceride peak rises and iAUCs.</p><p id="P58">Second, we performed cross-sectional analyses of DNAm at either 30m or 4h. DNAm residuals adjusted for timepoint and covariates were used due to the smaller number of samples included cross-sectionally (≈ one third of the original sample size). We tested DNAm associations with glucose at fasting, 30m and 4h, triglycerides at fasting and 4h, and their overall peak rises and iAUCs. Linear regression models were employed in this case. Thirty-minute and 4-hour DNAm associations with fasted glucose and triglycerides were performed to investigate role of participant health in determining postprandial DNAm levels.</p><p id="P59">Finally, we tested associations between fasting DNAm and postprandial glucose and triglycerides. For this, we used linear models where residuals of DNAm at fasting baseline were the predictors of changes in glucose and triglycerides at fasting, 30m, and 4h, as well as their overall peak rises and iAUCs. In addition, we used DNAm at 30m to predict 4h glucose and 4h triglycerides.</p><p id="P60">DNAm and expression associations with the phenotypes were overall inflated and Bacon correction<sup><xref ref-type="bibr" rid="R103">103</xref></sup> of <italic>p</italic>-values was employed. Despite this, gene expression results remained overwhelmingly inflated (highest λ = 2.3 after Bacon) so we used them only to cross-validate findings from DNAm in this study. Results are reported after multiple testing FDR = 5%, and signals from the main postprandial analyses, <italic>i.e.:</italic> timepoint analyses (<xref ref-type="supplementary-material" rid="SD1">Tables S1, S6 and S12</xref>), that have nominal significance with the phenotypes are also reported (<italic>p</italic> &lt; 0.05). Cross-sectional and baseline gene expression are not reported due limited number of samples available to perform the analyses (expression n<sub>max</sub> = 50 samples per timepoint).</p></sec><sec id="S26"><title>Analysis of epigenetic aging link to postprandial glucose and triglycerides</title><p id="P61">The epigenetic age acceleration (EAA) of participants at fasting baseline was used to predict changes in the blood glucose and triglycerides of participants after meal. For this we used 6 variables of EAA – AgeAccelerationResidual, AgeAccelerationResidualHannum, AgeAccelPheno, AgeAccelGrim, AgeAccelGrim 2 and DunedinPACE – in association with glucose and triglyceride levels at fasting, glucose levels at 30m postprandially, triglyceride levels at 4h postprandially, glucose 2h peak rise and iAUC, and triglycerides 4h peak rise and iAUC. Linear mixed models were adjusted for the same covariates used in the main postprandial analyses except for age at visit since EAA already accounts for chronological age. All EAAs were calculated using Horvath’s calculator<sup><xref ref-type="bibr" rid="R58">58</xref></sup> apart from DunedinPACE <sup><xref ref-type="bibr" rid="R63">63</xref></sup>, where we used the DunedinPACE R package (<ext-link ext-link-type="uri" xlink:href="https://github.com/danbelsky/DunedinPACE">https://github.com/danbelsky/DunedinPACE</ext-link>) with standard parameter values, and GrimAge 2<sup><xref ref-type="bibr" rid="R62">62</xref></sup>.</p></sec><sec id="S27"><title>Replication of DNAm and gene expression signals</title><p id="P62">The GOLDN study<sup><xref ref-type="bibr" rid="R5">5</xref></sup> associated DNAm at baseline with postprandial triglycerides, while Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup> profiled DNAm and expression postprandially at 160m to study changes in relation to fasting. Here, we used previously published data from Rask-Andersen et al. and the GOLDN cohort to perform a replication analysis of their findings in our trajectory and triglycerides associations, respectively. The GOTO study<sup><xref ref-type="bibr" rid="R14">14</xref></sup> collected transcriptomes at fasting baseline and 30m postprandially, pre- and post-combined nutritional and physical intervention, and we replicated our expression trajectory results in this cohort. Replication results are presented after Bonferroni correction of <italic>p-</italic> values (<italic>p =</italic> 0.05/no. of probes or genes).</p></sec></sec><sec id="S28"><title>Exploration of changes to postprandial blood cell composition</title><p id="P63">After findings by Rask-Andersen et al.<sup><xref ref-type="bibr" rid="R6">6</xref></sup> we evaluated whether the postprandial DNAm signals captured in our analyses were being driven by changes in blood composition after meal. For this, we performed Wilcoxon signed ranks tests (and the Kruskal-Wallis test in PREDICT) to capture overall changes in blood using the Houseman et al. <sup><xref ref-type="bibr" rid="R94">94</xref></sup> blood cell count proportions estimated in our study. CD4+ T cell DNAm profiles were also available for a subset of mixed-sex participants in PREDICT. As such, we compared the directions of effect from our main postprandial lipemia analysis to the effects observed at 4h in CD4+ T cells. For this, we used raw DNAm β-values from a matched 10-participant subsample with whole blood and CD4+ T cells available. We tested changes in <italic>27</italic> CpGs showing the same directions of effect before and after adjustment for covariates in PREDICT, and report the directions of effect across observed in whole blood and CD4+ T cells, as well as their overall DNAm trajectory in our study.</p></sec><sec id="S29"><title>Gene ontology and pathway enrichment analysis</title><p id="P64">The peak 200 genes with the lowest P-values from our main DNAm and expression results were selected for term enrichment analysis with Enrichr<sup><xref ref-type="bibr" rid="R104">104</xref></sup>. Enrichment was performed across 5 databases, i.e.: GO Biological Process (v. 2023), GO Molecular Function (v. 2023), KEGG (v. 2021), Reactome (v. 2022) and Wikipathway (v. 2023). Background gene lists comprised all autosomal genes analysed in this study: 25,269 genes, 25,292 genes and 23,042 genes from the 4h DNAm meta-analysis, DNAm trajectory analysis and expression trajectory analysis, respectively. Only signals with low heterogeneity were included among the peak 200 signals from the 4h DNAm meta-analysis results. Significance of term enrichment was assessed with FDR = 5%.</p><p id="P65">Common genes from both DNAm and expression results were selected at a nominal P-value (<italic>p</italic> &lt; 0.05) and used for term enrichment here as well. Enrichment analysis was performed with Enrichr and the significance of terms was considered with FDR = 25%. In this case the background was comprised of only genes present in both the expression and DNAm datasets.</p></sec><sec id="S30"><title>EWAS and GWAS Catalog look-up</title><p id="P66">The peak 200 signals from the 4h epigenetic meta-analysis and epigenetic trajectory results were searched in the EWAS Catalog<sup><xref ref-type="bibr" rid="R28">28</xref></sup> to perform term enrichment analysis. For this, traits with similar or redundant names were merged, Fisher’s exact tests were conducted, and significant enrichment of terms is reported with FDR = 5%. Second, genes that passed the multiple testing threshold (FDR = 5%) in our main DNAm and gene expression analysis were searched in the GWAS Catalog <sup><xref ref-type="bibr" rid="R44">44</xref></sup> and the terms of genes with SNPs are reported.</p></sec><sec id="S31"><title>Cross-reference of signals against genetic effects</title><p id="P67">CpGs from the main epigenetic results of this study (<xref ref-type="supplementary-material" rid="SD1">Tables S1 and S6</xref>) were cross-referenced against the MeQTL EPIC Database (<ext-link ext-link-type="uri" xlink:href="https://epicmeqtl.kcl.ac.uk/">https://epicmeqtl.kcl.ac.uk/</ext-link>)<sup><xref ref-type="bibr" rid="R38">38</xref></sup> to determine the genetic effects on the DNAm signals reported. Similarly, genes from the main expression trajectory results (<xref ref-type="supplementary-material" rid="SD1">Table S12</xref>) were cross-referenced against the eQTLGen phase I database<sup><xref ref-type="bibr" rid="R39">39</xref></sup> to evaluate genetic effects on the expression signals reported. DNAm effects on expression (eQTM) were searched in the BIOS database<sup><xref ref-type="bibr" rid="R105">105</xref></sup>. MeQTLs, eQTLs and eQTMs were considered at the threshold reported by the authors (FDR = 5% across databases). Only cis-meQTLs and cis-eQTMs from MeQTL EPIC Database and BIOS were considered while both cis and trans-eQTLs from eQTLGen phase I are reported.</p></sec><sec id="S32"><title>Genetic colocalization analysis</title><p id="P68">A total of 18 CpG–gene pairs with the same meQTL/eQTL SNP were identified from the MeQTL EPIC Database (<ext-link ext-link-type="uri" xlink:href="https://epicmeqtl.kcl.ac.uk/">https://epicmeqtl.kcl.ac.uk/</ext-link>)<sup><xref ref-type="bibr" rid="R38">38</xref></sup> and eQTLGen phase I database<sup><xref ref-type="bibr" rid="R39">39</xref></sup>. Afterwards genetic colocalization analysis was performed to search evidence of genetic regulation of postprandial DNAm and gene expression. Bayesian genetic colocalization was performed according to Giambartolomei et al.<sup><xref ref-type="bibr" rid="R106">106</xref></sup>. For this, cis-meQTLs from the MeQTL EPIC Database were selected within 1 Mbp of target CpGs and matched cis-eQTL SNPs were selected from the eQTLGen Phase I summary statistics. Genetic variants from both datasets were harmonised, and SNPs with more than 0.1 difference in estimated minor allele frequency between the two studies were discarded. Prior probabilities for the SNPs were estimated and colocalization was performed assuming a single causal variant, using the R package coloc<sup><xref ref-type="bibr" rid="R106">106</xref></sup> and the function <italic>coloc.abf.</italic> CpG–gene pairs were considered to have strong evidence of colocalization if the posterior probability was higher than 0.8 (<italic>i.e.:</italic> P(H4) &gt; 0.80). Sensitivity analysis was performed to validate the robustness of the results. For this, we used the <italic>coloc.abf</italic> function with the default prior probabilities (<italic>p<sub>1</sub></italic> = <italic>p<sub>2</sub></italic> = 1E-04, <italic>p<sub>12</sub></italic>= 1E-05), and then used the sensitivity function to search evidence for colocalization while varying <italic>p<sub>12</sub></italic> values. Further details on the CpG-gene pairs tested and the estimation of priors is included in the Supplementary Information file.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplemental Tables</label><media xlink:href="EMS201670-supplement-Supplemental_Tables.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d200aAcFbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplemental Text and Figures</label><media xlink:href="EMS201670-supplement-Supplemental_Text_and_Figures.docx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document" id="d200aAcFcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S33"><title>Acknowledgements</title><p>We thank the participants and clinical teams of the PREDICT, TwinsUK, CORDIOPREV and GOTO studies. We thank the the Córdoba branch of the Biobank of the Sistema Sanitario Público de Andalucía (Andalusia, Spain) for providing the human biological samples for CORDIOPREV. We would also like to thank the EASP (Escuela Andaluza de Salud Publica), Granada, Spain, which performed the randomization process for CORDIOPREV.</p><p>We acknowledge use of King’s Computational Research, Engineering and Technology Environment (CREATE, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18742/rnvf-m076">https://doi.org/10.18742/rnvf-m076</ext-link>) in this work.</p><sec id="S34"><title>Funding statement</title><p>This project was supported by the European HDHL Joint Programming Initiative funding scheme DIMENSION project (BBSRC BB/S020845/1 and BB/T019980/1 to JTB, 01EA1902A to MW). The TwinsUK study is funded by the Wellcome Trust, Medical Research Council, Versus Arthritis, European Union Horizon 2020, Chronic Disease Research Foundation (CDRF), ZOE LIMITED, and the National Institute for Health Research (NIHR) Clinical Research Network (CRN) and Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust in partnership with King’s College London. PREDICT was co-funded by ZOE Ltd.</p><p>The CORDIOPREV study is supported by the Fundación Patrimonio Comunal Olivarero, Junta de Andalucía (Consejería de Salud, Consejería de Agricultura y Pesca, Consejería de Innovación, Ciencia y Empresa), Diputaciones de Jaén y Córdoba, Centro de Excelencia en Investigación sobre Aceite de Oliva y Salud and Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de España; Ministerio de Economía y Competitividad (AGL2012/39615, PIE14/00005, PIE 14/00031 and AGL2015-67896-P to JL-M); Consejería de Innovación, Ciencia y Empresa, Proyectos de Investigación de Excelencia, Junta de Andalucía (CVI-7450 to JL-M); and by the Fondo Europeo de Desarrollo Regional (FEDER), JPI HDHL-NutriCog (PCIN-2016-084 to JL-M). The CIBEROBN is an initiative of the Instituto de Salud Carlos III, Madrid, Spain. OR-Z is supported by an ISCIII research contract (Programa Miguel-Servet CP19/00142 funded by Instituto de Salud Carlos III, and co-funded by the Fondo Social Europeo “El FSE invierte en tu futuro”). The epigenetic and genetic studies from CORDIOPREV are funded by the Instituto de Salud Carlos III in the framework of the FIS projects (PI22/01020 to OR-Z; PI22/01962 JFA-D). The CORDIOPREV study is further funded by the PROYECTOS DE I+D+I «PROGRAMACIÓN CONJUNTA INTERNACIONAL» of the Minsiterio de Ciencia, Innovación y Universidades (PCI2018-093009).</p></sec></ack><sec id="S35" sec-type="data-availability"><title>Data availability</title><p id="P69">The epigenetic and transcriptomic data from PREDICT/TwinsUK is available through EGA [ID] for DNAm and EGA [ID] for gene expression. Additional PREDICT/TwinsUK individual-level data are not permitted to be shared or deposited due to the original consent given at the time of data collection. However, access to these data can be applied for through the TwinsUK data access committee. For information on access and how to apply <ext-link ext-link-type="uri" xlink:href="http://twinsuk.ac.uk/resources-for-researchers/access-our-data/">http://twinsuk.ac.uk/resources-for-researchers/access-our-data/</ext-link>.</p><p id="P70">In relation to the epigenetic data from CORDIOPREV Study, collaborations with the study are open to Biomedical Institutions, always after an accepted proposal for scientific work. Depending on the nature of the collaboration, electronic data, hard copy data, or biological samples should be provided. All collaborations will be made after a collaboration agreement. Terms of the collaboration agreement will be specific for each collaboration, and the extent of the shared documentation (i.e., deidentified participant data, data dictionary, biological samples, hard copy, or other specified data sets) will be also specifically set on the light of each work.</p></sec><fn-group><title>Declarations</title><fn id="FN1" fn-type="con"><p id="P71"><bold>Author contributions</bold></p><p id="P72">JTB, SEB and JMO designed the study. JTB oversaw the study with inputs from JMO and SEB. RC led the analysis. LDR, JMO, JFA-D, OR-Z and JL-M contributed to data acquisition. MW oversaw epigenetic profiling. TG, FB, SV, LS, YR, MT, CC, LDR, MW, PES contributed to data processing and analysis, and results interpretation. KSS, BTH and TDS contributed to results interpretation. RC and JTB wrote the manuscript. RC and SV prepared visualisation of results. All authors reviewed and approved the manuscript.</p></fn><fn id="FN2"><p id="P73"><bold>Ethics approval</bold></p><p id="P74"><bold>PREDICT/TwinsUK:</bold> Ethical approval was granted by the National Research Ethics Service London- Westminster, the St Thomas’ Hospital Research Ethics Committee (EC04/015 and 07/H0802/84). All research participants have signed informed consent prior to taking part in any research activities.</p><p id="P75"><bold>CORDIOPREV:</bold> Ethical approval was granted by the Ethics Committee from Reina Sofia University Hospital (No. 1496/27/03/2009), following the principles of the Helsinki Declaration and good clinical practices. All research participants have signed informed consent prior to taking part in any research activities. The study is registered in Clinicaltrials.gov (NTC00924937).</p></fn><fn id="FN3"><p id="P76"><bold>Consent for publication</bold></p><p id="P77">All authors have read and approved the manuscript for publication.</p></fn><fn id="FN4" fn-type="conflict"><p id="P78"><bold>Competing interests</bold></p><p id="P79">TDS is a co-founder of ZOE Ltd. TDS and SEB are consultants to ZOE Ltd. TDS and SEB are in receipt of ZOE options. The other authors have no competing interests to declare.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>SE</given-names></name><name><surname>Valdes</surname><given-names>AM</given-names></name><name><surname>Drew</surname><given-names>DA</given-names></name><name><surname>Asnicar</surname><given-names>E</given-names></name><name><surname>Mazidi</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>J</given-names></name><name><surname>Capdevila</surname><given-names>J</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>R</given-names></name><name><surname>Al Khatib</surname><given-names>H</given-names></name><etal/></person-group><article-title>Human postprandial responses to food and potential for precision nutrition</article-title><source>Nat Med</source><year>2020</year><volume>26</volume><fpage>964</fpage><lpage>973</lpage><pub-id pub-id-type="pmcid">PMC8265154</pub-id><pub-id pub-id-type="pmid">32528151</pub-id><pub-id pub-id-type="doi">10.1038/s41591-020-0934-0</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Keefe</surname><given-names>JH</given-names></name><name><surname>Bell</surname><given-names>DSH</given-names></name></person-group><article-title>Postprandial Hyperglycemia/Hyperlipidemia (Postprandial Dysmetaholism) Is a Cardiovascular Risk Factor</article-title><source>American Journal of Cardiology</source><year>2007</year><volume>100</volume><fpage>899</fpage><lpage>904</lpage><pub-id pub-id-type="pmid">17719342</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhar</surname><given-names>GA</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Mitra</surname><given-names>P</given-names></name><name><surname>Nag Chaudhuri</surname><given-names>R</given-names></name></person-group><article-title>DNA methylation and regulation of gene expression: Guardian of our health</article-title><source>Nucleus (India)</source><year>2021</year><volume>64</volume><fpage>259</fpage><lpage>270</lpage><pub-id pub-id-type="pmcid">PMC8366481</pub-id><pub-id pub-id-type="pmid">34421129</pub-id><pub-id pub-id-type="doi">10.1007/s13237-021-00367-y</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heilbach</surname><given-names>F</given-names></name><name><surname>Sinke</surname><given-names>L</given-names></name><name><surname>Costeira</surname><given-names>R</given-names></name><name><surname>Baumeister</surname><given-names>SE</given-names></name><name><surname>Beekman</surname><given-names>M</given-names></name><name><surname>Louca</surname><given-names>P</given-names></name><name><surname>Leeming</surname><given-names>ER</given-names></name><name><surname>Mompeo</surname><given-names>O</given-names></name><name><surname>Berry</surname><given-names>S</given-names></name><name><surname>Wilson</surname><given-names>R</given-names></name><etal/></person-group><article-title>Pooled analysis of epigenome-wide association studies of food consumption in KORA, TwinsUK and LLS</article-title><source>Eur J Nutr</source><year>2022</year><pub-id pub-id-type="pmcid">PMC10030421</pub-id><pub-id pub-id-type="pmid">36571600</pub-id><pub-id pub-id-type="doi">10.1007/s00394-022-03074-9</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>CQ</given-names></name><name><surname>Wojczynski</surname><given-names>MK</given-names></name><name><surname>Parnell</surname><given-names>LD</given-names></name><name><surname>Hidalgo</surname><given-names>BA</given-names></name><name><surname>Irvin</surname><given-names>MR</given-names></name><name><surname>Aslibekyan</surname><given-names>S</given-names></name><name><surname>Province</surname><given-names>MA</given-names></name><name><surname>Absher</surname><given-names>DM</given-names></name><name><surname>Arnett</surname><given-names>DK</given-names></name><name><surname>Ordovás</surname><given-names>JM</given-names></name></person-group><article-title>Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge</article-title><source>J Lipid Res</source><year>2016</year><volume>57</volume><fpage>2200</fpage><lpage>2207</lpage><pub-id pub-id-type="pmcid">PMC5321216</pub-id><pub-id pub-id-type="pmid">27777315</pub-id><pub-id pub-id-type="doi">10.1194/jlr.M069948</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rask-Andersen</surname><given-names>M</given-names></name><name><surname>Bringeland</surname><given-names>N</given-names></name><name><surname>Nilsson</surname><given-names>EK</given-names></name><name><surname>Bandstein</surname><given-names>M</given-names></name><name><surname>Búcaro</surname><given-names>MO</given-names></name><name><surname>Vogel</surname><given-names>H</given-names></name><name><surname>Schürmann</surname><given-names>A</given-names></name><name><surname>Hogenkamp</surname><given-names>PS</given-names></name><name><surname>Benedict</surname><given-names>C</given-names></name><name><surname>Schiöth</surname><given-names>HB</given-names></name></person-group><article-title>Postprandial alterations in whole-blood DNA methylation are mediated by changes in white blood cell composition</article-title><source>American Journal of Clinical Nutrition</source><year>2016</year><volume>104</volume><fpage>518</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">27385611</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pescador-Tapia</surname><given-names>A</given-names></name><name><surname>Silva-Martinez</surname><given-names>GA</given-names></name><name><surname>Fragoso-Bargas</surname><given-names>N</given-names></name><name><surname>Rodríguez-Ríos</surname><given-names>D</given-names></name><name><surname>Esteller</surname><given-names>M</given-names></name><name><surname>Moran</surname><given-names>S</given-names></name><name><surname>Zaina</surname><given-names>S</given-names></name><name><surname>Lund</surname><given-names>G</given-names></name></person-group><article-title>Distinct Associations of BMI and Fatty Acids With DNA Methylation in Fasting and Postprandial States in Men</article-title><source>Front Genet</source><year>2021</year><volume>12</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmcid">PMC8138173</pub-id><pub-id pub-id-type="pmid">34025721</pub-id><pub-id pub-id-type="doi">10.3389/fgene.2021.665769</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakubowicz</surname><given-names>D</given-names></name><name><surname>Wainstein</surname><given-names>J</given-names></name><name><surname>Landau</surname><given-names>Z</given-names></name><name><surname>Raz</surname><given-names>I</given-names></name><name><surname>Ahren</surname><given-names>B</given-names></name><name><surname>Chapnik</surname><given-names>N</given-names></name><name><surname>Ganz</surname><given-names>T</given-names></name><name><surname>Menaged</surname><given-names>M</given-names></name><name><surname>Barnea</surname><given-names>M</given-names></name><name><surname>Bar-Dayan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Influences of breakfast on clock gene expression and postprandial glycemia in healthy individuals and individuals with diabetes: A randomized clinical trial</article-title><source>Diabetes Care</source><year>2017</year><volume>40</volume><fpage>1573</fpage><lpage>1579</lpage><pub-id pub-id-type="pmid">28830875</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonham</surname><given-names>MP</given-names></name><name><surname>Kaias</surname><given-names>E</given-names></name><name><surname>Huggins</surname><given-names>CE</given-names></name><name><surname>Davis</surname><given-names>R</given-names></name><name><surname>Leung</surname><given-names>GK</given-names></name><name><surname>Eikelis</surname><given-names>N</given-names></name><name><surname>Shaw</surname><given-names>E</given-names></name><name><surname>Murgia</surname><given-names>C</given-names></name></person-group><article-title>Effects of macronutrient manipulation on postprandial metabolic responses in overweight males with high fasting lipids during simulated shift work: A randomized crossover trial</article-title><source>Clinical Nutrition</source><year>2020</year><volume>39</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">30853262</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Grada</surname><given-names>CM</given-names></name><name><surname>Morine</surname><given-names>MJ</given-names></name><name><surname>Morris</surname><given-names>C</given-names></name><name><surname>Ryan</surname><given-names>M</given-names></name><name><surname>Dillon</surname><given-names>ET</given-names></name><name><surname>Walsh</surname><given-names>M</given-names></name><name><surname>Gibney</surname><given-names>ER</given-names></name><name><surname>Brennan</surname><given-names>L</given-names></name><name><surname>Gibney</surname><given-names>MJ</given-names></name><name><surname>Roche</surname><given-names>HM</given-names></name></person-group><article-title>PBMCs reflect the immune component of the WAT transcriptome-lmplications as biomarkers of metabolic health in the postprandial state</article-title><source>Mol Nutr Food Res</source><year>2014</year><volume>58</volume><fpage>808</fpage><lpage>820</lpage><pub-id pub-id-type="pmid">24170299</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazelzadeh</surname><given-names>P</given-names></name><name><surname>Hangelbroek</surname><given-names>RWJ</given-names></name><name><surname>Joris</surname><given-names>PJ</given-names></name><name><surname>Schalkwijk</surname><given-names>CG</given-names></name><name><surname>Esser</surname><given-names>D</given-names></name><name><surname>Afman</surname><given-names>L</given-names></name><name><surname>Hankemeier</surname><given-names>T</given-names></name><name><surname>Jacobs</surname><given-names>DM</given-names></name><name><surname>Mihaleva</surname><given-names>VV</given-names></name><name><surname>Kersten</surname><given-names>S</given-names></name><etal/></person-group><article-title>Weight loss moderately affects the mixed meal challenge response of the plasma metabolome and transcriptome of peripheral blood mononuclear cells in abdominally obese subjects</article-title><source>Metabolomics</source><year>2018</year><volume>14</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC5838115</pub-id><pub-id pub-id-type="pmid">29527144</pub-id><pub-id pub-id-type="doi">10.1007/s11306-018-1328-x</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>KJ</given-names></name><name><surname>Pimentel</surname><given-names>G</given-names></name><name><surname>Zangger</surname><given-names>N</given-names></name><name><surname>Vionnet</surname><given-names>N</given-names></name><name><surname>Drai</surname><given-names>J</given-names></name><name><surname>McTernan</surname><given-names>PG</given-names></name><name><surname>Pralong</surname><given-names>FP</given-names></name><name><surname>Delorenzi</surname><given-names>M</given-names></name><name><surname>Vergères</surname><given-names>G</given-names></name></person-group><article-title>Modulation of the peripheral blood transcriptome by the ingestion of probiotic yoghurt and acidified milk in healthy, young men</article-title><source>PLoS One</source><year>2018</year><volume>13</volume><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="pmcid">PMC5831037</pub-id><pub-id pub-id-type="pmid">29489876</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0192947</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Rest</surname><given-names>O</given-names></name><name><surname>Schutte</surname><given-names>BAM</given-names></name><name><surname>Deelen</surname><given-names>J</given-names></name><name><surname>Stassen</surname><given-names>SAM</given-names></name><name><surname>van den Akker</surname><given-names>EB</given-names></name><name><surname>van Heemst</surname><given-names>D</given-names></name><name><surname>Dibbets-Schneider</surname><given-names>P</given-names></name><name><surname>van Dipten-van der Veen</surname><given-names>Regina A</given-names></name><name><surname>Kelderman</surname><given-names>M</given-names></name><name><surname>Hankemeier</surname><given-names>T</given-names></name><etal/></person-group><article-title>Metabolic effects of a 13-weeks lifestyle intervention in older adults: The Growing Old Together Study</article-title><source>Aging</source><year>2016</year><volume>8</volume><fpage>111</fpage><lpage>124</lpage><pub-id pub-id-type="pmcid">PMC4761717</pub-id><pub-id pub-id-type="pmid">26824634</pub-id><pub-id pub-id-type="doi">10.18632/aging.100877</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehrmann</surname><given-names>T</given-names></name><name><surname>Beekman</surname><given-names>M</given-names></name><name><surname>Deelen</surname><given-names>J</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Van De Rest</surname><given-names>O</given-names></name><name><surname>Mei</surname><given-names>L</given-names></name><name><surname>Raz</surname><given-names>Y</given-names></name><name><surname>De Groot</surname><given-names>L</given-names></name><name><surname>Van Der Breggen</surname><given-names>R</given-names></name><name><surname>Reinders</surname><given-names>MJT</given-names></name><etal/></person-group><article-title>A combined lifestyle intervention induces a sensitization of the blood transcriptomic response to a nutrient challenge</article-title><source>bioRxiv</source><year>2021</year><elocation-id>2021.05.18.444591</elocation-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>SE</given-names></name><name><surname>Valdes</surname><given-names>AM</given-names></name><name><surname>Drew</surname><given-names>DA</given-names></name><name><surname>Asnicar</surname><given-names>F</given-names></name><name><surname>Mazidi</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>J</given-names></name><name><surname>Capdevila</surname><given-names>J</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>G</given-names></name><name><surname>Davies</surname><given-names>R</given-names></name><name><surname>Al Khatib</surname><given-names>H</given-names></name><etal/></person-group><article-title>Human postprandial responses to food and potential for precision nutrition</article-title><source>Nat Med</source><year>2020</year><volume>26</volume><fpage>964</fpage><lpage>973</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-0934-0</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado-Lista</surname><given-names>J</given-names></name><name><surname>Alcala-Diaz</surname><given-names>JF</given-names></name><name><surname>Torres-Peña</surname><given-names>JD</given-names></name><name><surname>Quintana-Navarro</surname><given-names>GM</given-names></name><name><surname>Fuentes</surname><given-names>F</given-names></name><name><surname>Garcia-Rios</surname><given-names>A</given-names></name><name><surname>Ortiz-Morales</surname><given-names>AM</given-names></name><name><surname>Gonzalez-Requero</surname><given-names>AI</given-names></name><name><surname>Perez-Caballero</surname><given-names>AI</given-names></name><name><surname>Yubero-Serrano</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Long-term secondary prevention of cardiovasculardisease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial</article-title><source>The Lancet</source><year>2022</year><volume>399</volume><fpage>1876</fpage><lpage>1885</lpage><pub-id pub-id-type="pmid">35525255</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirillo</surname><given-names>A</given-names></name><name><surname>Norata</surname><given-names>GD</given-names></name><name><surname>Catapano</surname><given-names>AL</given-names></name></person-group><article-title>Postprandial lipemia as a cardiometabolic risk factor</article-title><source>Curr Med Res Opin</source><year>2014</year><volume>30</volume><fpage>1489</fpage><lpage>1503</lpage><pub-id pub-id-type="pmid">24673475</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivetac</surname><given-names>I</given-names></name><name><surname>Gurung</surname><given-names>R</given-names></name><name><surname>Hakim</surname><given-names>S</given-names></name><name><surname>Horan</surname><given-names>KA</given-names></name><name><surname>Sheffield</surname><given-names>DA</given-names></name><name><surname>Binge</surname><given-names>LC</given-names></name><name><surname>Majerus</surname><given-names>PW</given-names></name><name><surname>Tiganis</surname><given-names>T</given-names></name><name><surname>Mitchell</surname><given-names>CA</given-names></name></person-group><article-title>Regulation of PI (3)K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-l</article-title><source>EMBO Rep</source><year>2009</year><volume>10</volume><fpage>487</fpage><lpage>493</lpage><pub-id pub-id-type="pmcid">PMC2680870</pub-id><pub-id pub-id-type="pmid">19325558</pub-id><pub-id pub-id-type="doi">10.1038/embor.2009.28</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname><given-names>LM</given-names></name><name><surname>Frisdal</surname><given-names>E</given-names></name><name><surname>Le Goff</surname><given-names>W</given-names></name></person-group><article-title>Critical role of the human ATP-binding cassette G1 transporter in cardiometabolic diseases</article-title><source>Int J Mol Sci</source><year>2017</year><volume>18</volume><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="pmcid">PMC5618541</pub-id><pub-id pub-id-type="pmid">28869506</pub-id><pub-id pub-id-type="doi">10.3390/ijms18091892</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes</article-title><source>Cell Rep</source><year>2019</year><volume>26</volume><fpage>884</fpage><lpage>892</lpage><elocation-id>e4</elocation-id><pub-id pub-id-type="pmid">30673611</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teodoro</surname><given-names>BG</given-names></name><name><surname>Sampaio</surname><given-names>IH</given-names></name><name><surname>Bomfim</surname><given-names>LHM</given-names></name><name><surname>Queiroz</surname><given-names>AL</given-names></name><name><surname>Silveira</surname><given-names>LR</given-names></name><name><surname>Souza</surname><given-names>AO</given-names></name><name><surname>Fernandes</surname><given-names>AMAP</given-names></name><name><surname>Eberlin</surname><given-names>MN</given-names></name><name><surname>Huang</surname><given-names>TY</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><etal/></person-group><article-title>Long-chain acyl-CoA synthetase 6 regulates lipid synthesis and mitochondrial oxidative capacity in human and rat skeletal muscle</article-title><source>Journal of Physiology</source><year>2017</year><volume>595</volume><fpage>677</fpage><lpage>693</lpage><pub-id pub-id-type="pmcid">PMC5285616</pub-id><pub-id pub-id-type="pmid">27647415</pub-id><pub-id pub-id-type="doi">10.1113/JP272962</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulkarni</surname><given-names>SS</given-names></name><name><surname>Singh</surname><given-names>O</given-names></name><name><surname>Zigman</surname><given-names>JM</given-names></name></person-group><article-title>The intersection between ghrelin, metabolism and circadian rhythms</article-title><source>Nature Reviews Endocrynology</source><year>2023</year><pub-id pub-id-type="pmid">38123819</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanagi</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name></person-group><article-title>The Homeostatic Force of Ghrelin</article-title><source>Cell Metab</source><year>2018</year><volume>27</volume><fpage>786</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">29576534</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinulescu</surname><given-names>DM</given-names></name><name><surname>Cone</surname><given-names>RD</given-names></name></person-group><article-title>Agouti and Agouti-related protein: Analogies and contrasts</article-title><source>Journal of Biological Chemistry</source><year>2000</year><volume>275</volume><fpage>6695</fpage><lpage>6698</lpage><pub-id pub-id-type="pmid">10702221</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno-Navarrete</surname><given-names>JM</given-names></name><name><surname>Jove</surname><given-names>M</given-names></name><name><surname>Ortega</surname><given-names>F</given-names></name><name><surname>Xifra</surname><given-names>G</given-names></name><name><surname>Ricart</surname><given-names>W</given-names></name><name><surname>Obis</surname><given-names>È</given-names></name><name><surname>Pamplona</surname><given-names>R</given-names></name><name><surname>Portero-Otin</surname><given-names>M</given-names></name><name><surname>Fernández-Real</surname><given-names>JM</given-names></name></person-group><article-title>Metabolomics uncovers the role of adipose tissue PDXK in adipogenesis and systemic insulin sensitivity</article-title><source>Diabetologia</source><year>2016</year><volume>59</volume><fpage>822</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">26831303</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martino</surname><given-names>MR</given-names></name><name><surname>Gutiérrez-Aguilar</surname><given-names>M</given-names></name><name><surname>Yiew</surname><given-names>NKH</given-names></name><name><surname>Lutkewitte</surname><given-names>AJ</given-names></name><name><surname>Singer</surname><given-names>JM</given-names></name><name><surname>McCommis</surname><given-names>KS</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Liss</surname><given-names>KHH</given-names></name><name><surname>Yoshino</surname><given-names>J</given-names></name><name><surname>Renkemeyer</surname><given-names>MK</given-names></name><etal/></person-group><article-title>Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids</article-title><source>Cell Rep</source><year>2022</year><volume>39</volume><pub-id pub-id-type="pmcid">PMC9121396</pub-id><pub-id pub-id-type="pmid">35476997</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2022.110733</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>ZQ</given-names></name></person-group><article-title>The PI3K/AKT pathway in obesity and type 2 diabetes</article-title><source>Int J Biol Sci</source><year>2018</year><volume>14</volume><fpage>1483</fpage><lpage>1496</lpage><pub-id pub-id-type="pmcid">PMC6158718</pub-id><pub-id pub-id-type="pmid">30263000</pub-id><pub-id pub-id-type="doi">10.7150/ijbs.27173</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battram</surname><given-names>T</given-names></name><name><surname>Yousefi</surname><given-names>P</given-names></name><name><surname>Crawford</surname><given-names>G</given-names></name><name><surname>Prince</surname><given-names>C</given-names></name><name><surname>Sheikhali Babaei</surname><given-names>M</given-names></name><name><surname>Sharp</surname><given-names>G</given-names></name><name><surname>Hatcher</surname><given-names>C</given-names></name><name><surname>Vega-Salas</surname><given-names>MJ</given-names></name><name><surname>Khodabakhsh</surname><given-names>S</given-names></name><name><surname>Whitehurst</surname><given-names>O</given-names></name><etal/></person-group><article-title>The EWAS Catalog: A database of epigenome-wide association studies</article-title><source>Wellcome Open Res</source><year>2022</year><volume>7</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC9096146</pub-id><pub-id pub-id-type="pmid">35592546</pub-id><pub-id pub-id-type="doi">10.12688/wellcomeopenres.17598.1</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollet</surname><given-names>IG</given-names></name><name><surname>Malm</surname><given-names>HA</given-names></name><name><surname>Wendt</surname><given-names>A</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Eliasson</surname><given-names>L</given-names></name></person-group><article-title>Integrator of stress responses calmodulin binding transcription activator 1 (Camtal) Regulates miR-212/miR-132 Expression and insulin secretion</article-title><source>Journal of Biological Chemistry</source><year>2016</year><volume>291</volume><fpage>18440</fpage><lpage>18452</lpage><pub-id pub-id-type="pmcid">PMC5000089</pub-id><pub-id pub-id-type="pmid">27402838</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M116.716860</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>CD</given-names></name><name><surname>Gholami</surname><given-names>K</given-names></name><name><surname>Lam</surname><given-names>SK</given-names></name><name><surname>Hoe</surname><given-names>SZ</given-names></name></person-group><article-title>A preliminary study of the effect of a high-salt diet on transcriptome dynamics in rat hypothalamic forebrain and brainstem cardiovascular control centers</article-title><source>PeerJ</source><year>2020</year><volume>2020</volume><fpage>1</fpage><lpage>35</lpage><pub-id pub-id-type="pmcid">PMC7059759</pub-id><pub-id pub-id-type="pmid">32175184</pub-id><pub-id pub-id-type="doi">10.7717/peerj.8528</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutierrez-Aguilar</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>A</given-names></name><name><surname>Marchand</surname><given-names>N</given-names></name><name><surname>Dumont</surname><given-names>P</given-names></name><name><surname>Woods</surname><given-names>SC</given-names></name><name><surname>de Launoit</surname><given-names>Y</given-names></name><name><surname>Seeley</surname><given-names>RJ</given-names></name><name><surname>Ulrich-Lai</surname><given-names>YM</given-names></name></person-group><article-title>The obesity-associated transcription factor ETV5 modulates circulating glucocorticoids</article-title><source>Physiol Behav</source><year>2015</year><volume>150</volume><fpage>38</fpage><lpage>42</lpage><pub-id pub-id-type="pmcid">PMC4546891</pub-id><pub-id pub-id-type="pmid">25813907</pub-id><pub-id pub-id-type="doi">10.1016/j.physbeh.2015.03.027</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceddia</surname><given-names>RP</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Shi</surname><given-names>F</given-names></name><name><surname>Crowder</surname><given-names>MK</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Kass</surname><given-names>DA</given-names></name><name><surname>Collins</surname><given-names>S</given-names></name></person-group><article-title>Increased Energy Expenditure and Protection From Diet-Induced Obesity in Mice Lacking the cGMP-Specific Phosphodiesterase PDE9</article-title><source>Diabetes</source><year>2021</year><volume>70</volume><fpage>2823</fpage><lpage>2836</lpage><pub-id pub-id-type="pmcid">PMC8660992</pub-id><pub-id pub-id-type="pmid">34620617</pub-id><pub-id pub-id-type="doi">10.2337/db21-0100</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>G</given-names></name><name><surname>Koncevičius</surname><given-names>K</given-names></name><name><surname>Ebrahimi</surname><given-names>S</given-names></name><name><surname>Carlucci</surname><given-names>M</given-names></name><name><surname>Groot</surname><given-names>DE</given-names></name><name><surname>Nair</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Kriščiũnas</surname><given-names>A</given-names></name><name><surname>Oh</surname><given-names>ES</given-names></name><name><surname>Labrie</surname><given-names>V</given-names></name><etal/></person-group><article-title>Circadian oscillations of cytosine modification in humans contribute to epigenetic variability, aging, and complex disease 06 Biological Sciences 0604 Genetics</article-title><source>Genome Biol</source><year>2019</year><volume>20</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmcid">PMC6317262</pub-id><pub-id pub-id-type="pmid">30606238</pub-id><pub-id pub-id-type="doi">10.1186/s13059-018-1608-9</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moody</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>GB</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Pan</surname><given-names>YX</given-names></name></person-group><article-title>Epigenetic regulation of carnitine palmitoyltransferase 1 (Cptla) by high fat diet</article-title><source>Biochim Biophys Acta Gene Regul Meeh</source><year>2019</year><volume>1862</volume><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">30605728</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Ge</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>W</given-names></name><etal/></person-group><article-title>PERI interaction with GPX1 regulates metabolic homeostasis under oxidative stress</article-title><source>Redox Biol</source><year>2020</year><volume>37</volume><pub-id pub-id-type="pmcid">PMC7484554</pub-id><pub-id pub-id-type="pmid">32896721</pub-id><pub-id pub-id-type="doi">10.1016/j.redox.2020.101694</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tajik</surname><given-names>F</given-names></name><name><surname>Fattahi</surname><given-names>F</given-names></name><name><surname>Rezagholizadeh</surname><given-names>F</given-names></name><name><surname>Bouzari</surname><given-names>B</given-names></name><name><surname>Babaheidarian</surname><given-names>P</given-names></name><name><surname>Baghai Wadji</surname><given-names>M</given-names></name><name><surname>Madjd</surname><given-names>Z</given-names></name></person-group><article-title>Nuclearoverexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmcid">PMC10632485</pub-id><pub-id pub-id-type="pmid">37938616</pub-id><pub-id pub-id-type="doi">10.1038/s41598-023-46484-3</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>CY</given-names></name><name><surname>Chang</surname><given-names>WC</given-names></name><name><surname>Wang</surname><given-names>JM</given-names></name></person-group><article-title>Biological roles of CCAAT/enhancer-binding protein delta during inflammation</article-title><source>J Biomed Sci</source><year>2015</year><volume>22</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmcid">PMC4318212</pub-id><pub-id pub-id-type="pmid">25591788</pub-id><pub-id pub-id-type="doi">10.1186/s12929-014-0110-2</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villicaña</surname><given-names>S</given-names></name><name><surname>Castillo-Fernandez</surname><given-names>J</given-names></name><name><surname>Hannon</surname><given-names>E</given-names></name><name><surname>Christiansen</surname><given-names>C</given-names></name><name><surname>Tsai</surname><given-names>PC</given-names></name><name><surname>Maddock</surname><given-names>J</given-names></name><name><surname>Kuh</surname><given-names>D</given-names></name><name><surname>Suderman</surname><given-names>M</given-names></name><name><surname>Power</surname><given-names>C</given-names></name><name><surname>Relton</surname><given-names>C</given-names></name><etal/></person-group><article-title>Genetic impacts on DNA methylation help elucidate regulatory genomic processes</article-title><source>Genome Biol</source><year>2023</year><volume>24</volume><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="pmcid">PMC10391992</pub-id><pub-id pub-id-type="pmid">37525248</pub-id><pub-id pub-id-type="doi">10.1186/s13059-023-03011-x</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Võsa</surname><given-names>U</given-names></name><name><surname>Claringbould</surname><given-names>A</given-names></name><name><surname>Westra</surname><given-names>HJ</given-names></name><name><surname>Bonder</surname><given-names>MJ</given-names></name><name><surname>Deelen</surname><given-names>P</given-names></name><name><surname>Zeng</surname><given-names>B</given-names></name><name><surname>Kirsten</surname><given-names>H</given-names></name><name><surname>Saha</surname><given-names>A</given-names></name><name><surname>Kreuzhuber</surname><given-names>R</given-names></name><name><surname>Yazar</surname><given-names>S</given-names></name><etal/></person-group><article-title>Large-scale cis- and trans-eQŢL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression</article-title><source>Nat Genet</source><year>2021</year><volume>53</volume><fpage>1300</fpage><lpage>1310</lpage><pub-id pub-id-type="pmcid">PMC8432599</pub-id><pub-id pub-id-type="pmid">34475573</pub-id><pub-id pub-id-type="doi">10.1038/s41588-021-00913-z</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Sadagopan</surname><given-names>N</given-names></name><name><surname>Dunkerly-Eyring</surname><given-names>B</given-names></name><name><surname>Rodriguez</surname><given-names>S</given-names></name><name><surname>Sarver</surname><given-names>DC</given-names></name><name><surname>Ceddia</surname><given-names>RP</given-names></name><name><surname>Murphy</surname><given-names>SA</given-names></name><name><surname>Knutsdottir</surname><given-names>H</given-names></name><name><surname>Jani</surname><given-names>VP</given-names></name><name><surname>Ashok</surname><given-names>D</given-names></name><etal/></person-group><article-title>Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice</article-title><source>Journal of Clinical Investigation</source><year>2021</year><volume>131</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmcid">PMC8553561</pub-id><pub-id pub-id-type="pmid">34618683</pub-id><pub-id pub-id-type="doi">10.1172/JCI148798</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceddia</surname><given-names>RP</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Shi</surname><given-names>F</given-names></name><name><surname>Crowder</surname><given-names>MK</given-names></name><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Kass</surname><given-names>DA</given-names></name><name><surname>Collins</surname><given-names>S</given-names></name></person-group><article-title>Increased Energy Expenditure and Protection From Diet-Induced Obesity in Mice Lacking the cGMP-Specific Phosphodiesterase PDE9</article-title><source>Diabetes</source><year>2021</year><volume>70</volume><fpage>2823</fpage><lpage>2836</lpage><pub-id pub-id-type="doi">10.2337/db21-0100</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>DI</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Cho</surname><given-names>GS</given-names></name><name><surname>Hamdani</surname><given-names>N</given-names></name><name><surname>Holewinski</surname><given-names>R</given-names></name><name><surname>Jo</surname><given-names>SH</given-names></name><name><surname>Danner</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Rainer</surname><given-names>PP</given-names></name><etal/></person-group><article-title>Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease</article-title><source>Nature</source><year>2015</year><volume>519</volume><fpage>472</fpage><lpage>476</lpage><pub-id pub-id-type="pmcid">PMC4376609</pub-id><pub-id pub-id-type="pmid">25799991</pub-id><pub-id pub-id-type="doi">10.1038/nature14332</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honma</surname><given-names>K</given-names></name><name><surname>Kamikubo</surname><given-names>M</given-names></name><name><surname>Mochizuki</surname><given-names>K</given-names></name><name><surname>Goda</surname><given-names>T</given-names></name></person-group><article-title>Insulin-induced inhibition of gluconeogenesis genes, including glutamic pyruvic transaminase 2, is associated with reduced histone acetylation in a human liver cell line</article-title><source>Metabolism</source><year>2017</year><volume>71</volume><fpage>118</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">28521864</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sollis</surname><given-names>E</given-names></name><name><surname>Mosaku</surname><given-names>A</given-names></name><name><surname>Abid</surname><given-names>A</given-names></name><name><surname>Buniello</surname><given-names>A</given-names></name><name><surname>Cerezo</surname><given-names>M</given-names></name><name><surname>Gil</surname><given-names>L</given-names></name><name><surname>Groza</surname><given-names>T</given-names></name><name><surname>Güneş</surname><given-names>O</given-names></name><name><surname>Hall</surname><given-names>P</given-names></name><name><surname>Hayhurst</surname><given-names>J</given-names></name><etal/></person-group><article-title>The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource</article-title><source>Nucleic Acids Res</source><year>2023</year><volume>51</volume><fpage>D977</fpage><lpage>D985</lpage><pub-id pub-id-type="pmcid">PMC9825413</pub-id><pub-id pub-id-type="pmid">36350656</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkac1010</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>MCJ</given-names></name><name><surname>Mennie</surname><given-names>AK</given-names></name><name><surname>Pettus</surname><given-names>JM</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Traxler</surname><given-names>MG</given-names></name><name><surname>Jakoubek</surname><given-names>J</given-names></name><name><surname>Atanur</surname><given-names>SS</given-names></name><name><surname>Altman</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Systems Biology with High-Throughput Sequencing Reveals Genetic Mechanisms Underlying the Metabolic Syndrome in the Lyon Hypertensive Rat</article-title><source>Circ Cardiovasc Genet</source><year>2015</year><volume>8</volume><fpage>316</fpage><lpage>326</lpage><pub-id pub-id-type="pmcid">PMC4406788</pub-id><pub-id pub-id-type="pmid">25573024</pub-id><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.114.000520</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name></person-group><article-title>Rab32 is important for autophagy and lipid storage in drosophila</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC3279429</pub-id><pub-id pub-id-type="pmid">22348149</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0032086</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>Z</given-names></name><name><surname>Zeeshan</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>BT</given-names></name></person-group><article-title>RNA-seq driven expression and enrichment analysis to investigate CVD genes with associated phenotypes among high-risk heart failure patients</article-title><source>Hum Genomics</source><year>2021</year><volume>15</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="pmcid">PMC8590246</pub-id><pub-id pub-id-type="pmid">34774109</pub-id><pub-id pub-id-type="doi">10.1186/s40246-021-00367-8</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Dodson</surname><given-names>MV</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Differential display of expressed genes reveals a novel function of SFRS18 in regulation of intramuscular fat deposition</article-title><source>Int J Biol Sci</source><year>2009</year><volume>5</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="pmcid">PMC2605576</pub-id><pub-id pub-id-type="pmid">19119313</pub-id><pub-id pub-id-type="doi">10.7150/ijbs.5.28</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wijenayake</surname><given-names>S</given-names></name><name><surname>Rahman</surname><given-names>MF</given-names></name><name><surname>Lum</surname><given-names>CMW</given-names></name><name><surname>De Vega</surname><given-names>WC</given-names></name><name><surname>Sasaki</surname><given-names>A</given-names></name><name><surname>McGowan</surname><given-names>PO</given-names></name></person-group><article-title>Maternal high-fat diet induces sex-specific changes to glucocorticoid and inflammatory signaling in response to corticosterone and lipopolysaccharide challenge in adult rat offspring</article-title><source>J Neuroinflammation</source><year>2020</year><volume>17</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC7158103</pub-id><pub-id pub-id-type="pmid">32293490</pub-id><pub-id pub-id-type="doi">10.1186/s12974-020-01798-1</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edillor</surname><given-names>CR</given-names></name><name><surname>Parks</surname><given-names>BW</given-names></name><name><surname>Mehrabian</surname><given-names>M</given-names></name><name><surname>Lusis</surname><given-names>AJ</given-names></name><name><surname>Pellegrini</surname><given-names>M</given-names></name></person-group><article-title>DNA Methylation Changes More Slowly Than Physiological States in Response to Weight Loss in Genetically Diverse Mouse Strains</article-title><source>Front Endocrinol (Lausanne)</source><year>2019</year><volume>10</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC6933503</pub-id><pub-id pub-id-type="pmid">31920990</pub-id><pub-id pub-id-type="doi">10.3389/fendo.2019.00882</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>G</given-names></name><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><article-title>Reticulocalbin 2 enhances osteogenic differentiation of human vascular smooth muscle cells in diabetic conditions</article-title><source>Life Sci</source><year>2019</year><volume>233</volume><elocation-id>116746</elocation-id><pub-id pub-id-type="pmid">31401313</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Gong</surname><given-names>N</given-names></name><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Cui</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Jiao</surname><given-names>T</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Forkhead box Pl (FOXP1) transcription factor regulates hepatic glucose homeostasis</article-title><source>Journal of Biological Chemistry</source><year>2015</year><volume>290</volume><fpage>30607</fpage><lpage>30615</lpage><pub-id pub-id-type="pmcid">PMC4683280</pub-id><pub-id pub-id-type="pmid">26504089</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M115.681627</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Sukonina</surname><given-names>V</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Subhash</surname><given-names>S</given-names></name><name><surname>Palmgren</surname><given-names>H</given-names></name><name><surname>Alexandersson</surname><given-names>I</given-names></name><name><surname>Han</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Bartesaghi</surname><given-names>S</given-names></name><etal/></person-group><article-title>The transcription factor Foxpl regulates aerobic glycolysis in adipocytes and myocytes</article-title><source>J Biol Chem</source><year>2023</year><volume>299</volume><elocation-id>104795</elocation-id><pub-id pub-id-type="pmcid">PMC10244703</pub-id><pub-id pub-id-type="pmid">37150320</pub-id><pub-id pub-id-type="doi">10.1016/j.jbc.2023.104795</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>K</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Centrosomal protein of 55 regulates glucose metabolism, proliferation and apoptosis of Glioma cells via the Akt/mTOR signaling pathway</article-title><source>J Cancer</source><year>2016</year><volume>7</volume><fpage>1431</fpage><lpage>1440</lpage><pub-id pub-id-type="pmcid">PMC4964127</pub-id><pub-id pub-id-type="pmid">27471559</pub-id><pub-id pub-id-type="doi">10.7150/jca.15497</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venn</surname><given-names>BJ</given-names></name><name><surname>Williams</surname><given-names>SM</given-names></name><name><surname>Perry</surname><given-names>T</given-names></name><name><surname>Richardson</surname><given-names>S</given-names></name><name><surname>Cannon</surname><given-names>A</given-names></name><name><surname>Mann</surname><given-names>JI</given-names></name></person-group><article-title>Age-related differences in postprandial glycaemia and glycaemic index</article-title><source>Age Ageing</source><year>2011</year><volume>40</volume><fpage>755</fpage><lpage>758</lpage><pub-id pub-id-type="pmid">21795276</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basu</surname><given-names>R</given-names></name><name><surname>Man</surname><given-names>CD</given-names></name><name><surname>Campioni</surname><given-names>M</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name><name><surname>Klee</surname><given-names>G</given-names></name><name><surname>Toffolo</surname><given-names>G</given-names></name><name><surname>Cobelli</surname><given-names>C</given-names></name><name><surname>Rizza</surname><given-names>RA</given-names></name></person-group><article-title>Effects of age and sex on postprandial glucose metabolism differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction</article-title><source>Diabetes</source><year>2006</year><volume>55</volume><fpage>2001</fpage><lpage>2014</lpage><pub-id pub-id-type="pmid">16804069</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emerson</surname><given-names>SR</given-names></name><name><surname>Kurti</surname><given-names>SP</given-names></name><name><surname>Emerson</surname><given-names>EM</given-names></name><name><surname>Cull</surname><given-names>BJ</given-names></name><name><surname>Casey</surname><given-names>K</given-names></name><name><surname>Haub</surname><given-names>MD</given-names></name><name><surname>Rosenkranz</surname><given-names>SK</given-names></name></person-group><article-title>Postprandial Metabolic Responses Differ by Age Group and Physical Activity Level</article-title><source>J Nutr Health Aging</source><year>2018</year><volume>22</volume><fpage>145</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">29300434</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvath</surname><given-names>S</given-names></name></person-group><article-title>DNA methylation age of human tissues and cell types</article-title><source>Genome Biol</source><year>2013</year><volume>14</volume><pub-id pub-id-type="pmcid">PMC4015143</pub-id><pub-id pub-id-type="pmid">24138928</pub-id><pub-id pub-id-type="doi">10.1186/gb-2013-14-10-r115</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannum</surname><given-names>G</given-names></name><name><surname>Guinney</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Hughes</surname><given-names>G</given-names></name><name><surname>Sadda</surname><given-names>SV</given-names></name><name><surname>Klotzle</surname><given-names>B</given-names></name><name><surname>Bibikova</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>JB</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates</article-title><source>Mol Cell</source><year>2013</year><volume>49</volume><fpage>359</fpage><lpage>367</lpage><pub-id pub-id-type="pmcid">PMC3780611</pub-id><pub-id pub-id-type="pmid">23177740</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2012.10.016</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>AlDwyish</surname><given-names>A</given-names></name><name><surname>Tanin</surname><given-names>E</given-names></name><name><surname>Karunasekera</surname><given-names>S</given-names></name></person-group><source>Location-based social networking for obtaining personalised driving advice</source><conf-name>GIS: Proceedings of the ACM International Symposium on Advances in Geographic Information Systems</conf-name><conf-date>03-06-November-2015</conf-date><year>2015</year><fpage>573</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1145/2820783.2820789</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Protsenko</surname><given-names>E</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Nier</surname><given-names>B</given-names></name><name><surname>Reus</surname><given-names>V</given-names></name><name><surname>Hammamieh</surname><given-names>R</given-names></name><name><surname>Rampersaud</surname><given-names>R</given-names></name><name><surname>Wu</surname><given-names>GWY</given-names></name><name><surname>Hough</surname><given-names>CM</given-names></name><name><surname>Epel</surname><given-names>E</given-names></name><name><surname>Prather</surname><given-names>AA</given-names></name><etal/></person-group><article-title>“GrimAge,” an epigenetic predictor of mortality, is accelerated in major depressive disorder</article-title><source>Transi Psychiatry</source><year>2021</year><volume>11</volume><pub-id pub-id-type="pmcid">PMC8021561</pub-id><pub-id pub-id-type="pmid">33820909</pub-id><pub-id pub-id-type="doi">10.1038/s41398-021-01302-0</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>AT</given-names></name><name><surname>Binder</surname><given-names>AM</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>Q</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Cox</surname><given-names>SR</given-names></name><name><surname>Corley</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>SE</given-names></name><name><surname>Kuo</surname><given-names>PL</given-names></name><name><surname>Moore</surname><given-names>AZ</given-names></name><etal/></person-group><article-title>DNA methylation GrimAge version 2</article-title><source>Aging</source><year>2022</year><volume>14</volume><fpage>9484</fpage><lpage>9549</lpage><pub-id pub-id-type="pmcid">PMC9792204</pub-id><pub-id pub-id-type="pmid">36516495</pub-id><pub-id pub-id-type="doi">10.18632/aging.204434</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belsky</surname><given-names>DW</given-names></name><name><surname>Caspi</surname><given-names>A</given-names></name><name><surname>Corcoran</surname><given-names>DL</given-names></name><name><surname>Sugden</surname><given-names>K</given-names></name><name><surname>Poulton</surname><given-names>R</given-names></name><name><surname>Arseneault</surname><given-names>L</given-names></name><name><surname>Baccarelli</surname><given-names>A</given-names></name><name><surname>Chamarti</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Hannon</surname><given-names>E</given-names></name><etal/></person-group><article-title>DunedinPACE, A DNA methylation biomarker of the Pace of Aging</article-title><source>Elife</source><year>2022</year><volume>11</volume><fpage>1</fpage><lpage>26</lpage><pub-id pub-id-type="pmcid">PMC8853656</pub-id><pub-id pub-id-type="pmid">35029144</pub-id><pub-id pub-id-type="doi">10.7554/eLife.73420</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irvin</surname><given-names>MR</given-names></name><name><surname>Aslibekyan</surname><given-names>S</given-names></name><name><surname>Do</surname><given-names>A</given-names></name><name><surname>Zhi</surname><given-names>D</given-names></name><name><surname>Hidalgo</surname><given-names>B</given-names></name><name><surname>Claas</surname><given-names>SA</given-names></name><name><surname>Srinivasasainagendra</surname><given-names>V</given-names></name><name><surname>Horvath</surname><given-names>S</given-names></name><name><surname>Tiwari</surname><given-names>HK</given-names></name><name><surname>Absher</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study</article-title><source>Clin Epigenetics</source><year>2018</year><volume>10</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC5907301</pub-id><pub-id pub-id-type="pmid">29713391</pub-id><pub-id pub-id-type="doi">10.1186/s13148-018-0481-4</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lépine</surname><given-names>G</given-names></name><name><surname>Tremblay-Franco</surname><given-names>M</given-names></name><name><surname>Bouder</surname><given-names>S</given-names></name><name><surname>Dimina</surname><given-names>L</given-names></name><name><surname>Fouillet</surname><given-names>H</given-names></name><name><surname>Mariotti</surname><given-names>F</given-names></name><name><surname>Polakof</surname><given-names>S</given-names></name></person-group><article-title>Investigating the Postprandial Metabolome after Challenge Tests to Assess Metabolic Flexibility and Dysregulations Associated with Cardiometabolic Diseases</article-title><source>Nutrients</source><year>2022</year><volume>14</volume><pub-id pub-id-type="pmcid">PMC8840206</pub-id><pub-id pub-id-type="pmid">35276829</pub-id><pub-id pub-id-type="doi">10.3390/nu14030472</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Firouzi</surname><given-names>S</given-names></name><name><surname>Rezvani</surname><given-names>R</given-names></name><name><surname>Pahlavani</surname><given-names>N</given-names></name><name><surname>Jarahi</surname><given-names>L</given-names></name><name><surname>Navashenaq</surname><given-names>JG</given-names></name><name><surname>Ranjbar</surname><given-names>G</given-names></name><name><surname>Malekahmadi</surname><given-names>M</given-names></name><name><surname>Taherzadeh</surname><given-names>Z</given-names></name><name><surname>Safarian</surname><given-names>M</given-names></name></person-group><article-title>Postprandial effects of macronutrient composition meals on the metabolic responses and arterial stiffness indices of lean and obese male adults: a protocol of a pilot study</article-title><source>Pilot Feasibility Stud</source><year>2021</year><volume>7</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmcid">PMC7856746</pub-id><pub-id pub-id-type="pmid">33536071</pub-id><pub-id pub-id-type="doi">10.1186/s40814-021-00787-2</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>S</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><name><surname>Rifai</surname><given-names>N</given-names></name><name><surname>Mora</surname><given-names>S</given-names></name><name><surname>Sacks</surname><given-names>FM</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name></person-group><article-title>Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women</article-title><source>JAMA</source><year>2007</year><volume>298</volume><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">17635891</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordestgaard</surname><given-names>BG</given-names></name><name><surname>Benn</surname><given-names>M</given-names></name><name><surname>Schnohr</surname><given-names>P</given-names></name><name><surname>Tybjærg-Hansen</surname><given-names>A</given-names></name></person-group><article-title>Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women</article-title><source>JAMA</source><year>2007</year><volume>298</volume><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">17635890</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalot</surname><given-names>F</given-names></name><name><surname>Petrelli</surname><given-names>A</given-names></name><name><surname>Traversa</surname><given-names>M</given-names></name><name><surname>Bonomo</surname><given-names>K</given-names></name><name><surname>Flora</surname><given-names>E</given-names></name><name><surname>Conti</surname><given-names>M</given-names></name><name><surname>Anfossi</surname><given-names>G</given-names></name><name><surname>Costa</surname><given-names>G</given-names></name><name><surname>Trovati</surname><given-names>M</given-names></name></person-group><article-title>Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: Lessons from the San Luigi Gonzaga diabetes study</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><year>2006</year><volume>91</volume><fpage>813</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">16352690</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>J</given-names></name><name><surname>Diaz</surname><given-names>AN</given-names></name><name><surname>Gumz</surname><given-names>ML</given-names></name></person-group><article-title>Clock genes in hypertension: Novel insights from rodent models</article-title><source>Blood Press Monit</source><year>2014</year><volume>19</volume><fpage>249</fpage><lpage>254</lpage><pub-id pub-id-type="pmcid">PMC4159427</pub-id><pub-id pub-id-type="pmid">25025868</pub-id><pub-id pub-id-type="doi">10.1097/MBP.0000000000000060</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlaepfer</surname><given-names>IR</given-names></name><name><surname>Joshi</surname><given-names>M</given-names></name></person-group><article-title>CPTlA-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential</article-title><source>Endocrinology (United States)</source><year>2020</year><volume>161</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">31900483</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Acetyl-coenzyme A acyltransferase 2 promote the differentiation of sheep precursor adipocytes into adipocytes</article-title><source>J Cell Biochem</source><year>2019</year><volume>120</volume><fpage>8021</fpage><lpage>8031</lpage><pub-id pub-id-type="pmid">30485515</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frandsen</surname><given-names>J</given-names></name><name><surname>Poggi</surname><given-names>AI</given-names></name><name><surname>Ritz</surname><given-names>C</given-names></name><name><surname>Larsen</surname><given-names>S</given-names></name><name><surname>Delà</surname><given-names>F</given-names></name><name><surname>Helge</surname><given-names>JW</given-names></name></person-group><article-title>Peak Fat Oxidation Rate Is Closely Associated With Plasma Free Fatty Acid Concentrations in Women; Similar to Men</article-title><source>Front Physiol</source><year>2021</year><volume>12</volume><pub-id pub-id-type="pmcid">PMC8364948</pub-id><pub-id pub-id-type="pmid">34408659</pub-id><pub-id pub-id-type="doi">10.3389/fphys.2021.696261</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mardian</surname><given-names>EB</given-names></name><name><surname>Bradley</surname><given-names>RM</given-names></name><name><surname>Aristizabal Henao</surname><given-names>JJ</given-names></name><name><surname>Marvyn</surname><given-names>PM</given-names></name><name><surname>Moes</surname><given-names>KA</given-names></name><name><surname>Bombardier</surname><given-names>E</given-names></name><name><surname>Russell Tupling</surname><given-names>A</given-names></name><name><surname>Stark</surname><given-names>KD</given-names></name><name><surname>Duncan</surname><given-names>RE</given-names></name></person-group><article-title>Agpat4/Lpaat△ deficiency highlights the molecular heterogeneity of epididymal and perirenal white adipose depots</article-title><source>J Lipid Res</source><year>2017</year><volume>58</volume><fpage>2037</fpage><lpage>2050</lpage><pub-id pub-id-type="pmcid">PMC5625126</pub-id><pub-id pub-id-type="pmid">28814640</pub-id><pub-id pub-id-type="doi">10.1194/jlr.M079152</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Bi</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name></person-group><article-title>Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy</article-title><source>Front Oncol</source><year>2022</year><volume>12</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmcid">PMC9449579</pub-id><pub-id pub-id-type="pmid">36091156</pub-id><pub-id pub-id-type="doi">10.3389/fonc.2022.938502</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furlan</surname><given-names>V</given-names></name><name><surname>Bren</surname><given-names>U</given-names></name></person-group><article-title>Insight into inhibitory mechanism of pde4d by dietary polyphenols using molecular dynamics simulations and free energy calculations</article-title><source>Biomolecules</source><year>2021</year><volume>11</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="pmcid">PMC8004924</pub-id><pub-id pub-id-type="pmid">33806914</pub-id><pub-id pub-id-type="doi">10.3390/biom11030479</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zannas</surname><given-names>AS</given-names></name><name><surname>Wiechmann</surname><given-names>T</given-names></name><name><surname>Gassen</surname><given-names>NC</given-names></name><name><surname>Binder</surname><given-names>EB</given-names></name></person-group><article-title>Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications</article-title><source>Neuropsychopharmacology</source><year>2016</year><volume>41</volume><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type="pmcid">PMC4677131</pub-id><pub-id pub-id-type="pmid">26250598</pub-id><pub-id pub-id-type="doi">10.1038/npp.2015.235</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsevich</surname><given-names>G</given-names></name><name><surname>Uribe</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>KV</given-names></name><name><surname>Hartmann</surname><given-names>J</given-names></name><name><surname>Santarelli</surname><given-names>S</given-names></name><name><surname>Labermaier</surname><given-names>C</given-names></name><name><surname>Schmidt</surname><given-names>MV</given-names></name></person-group><article-title>Interplay between diet-induced obesity and chronic stress in mice: Potential role of FKBP51</article-title><source>Journal of Endocrinology</source><year>2014</year><volume>222</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">24781256</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cauchi</surname><given-names>S</given-names></name><name><surname>Proença</surname><given-names>C</given-names></name><name><surname>Choquet</surname><given-names>H</given-names></name><name><surname>Gaget</surname><given-names>S</given-names></name><name><surname>De Graeve</surname><given-names>F</given-names></name><name><surname>Marre</surname><given-names>M</given-names></name><name><surname>Balkau</surname><given-names>B</given-names></name><name><surname>Tichet</surname><given-names>J</given-names></name><name><surname>Meyre</surname><given-names>D</given-names></name><name><surname>Vaxillaire</surname><given-names>M</given-names></name><etal/></person-group><article-title>Analysis of novel risk loci for type 2 diabetes in a general French population: The D.E.S.I.R. study</article-title><source>J Mol Med</source><year>2008</year><volume>86</volume><fpage>341</fpage><lpage>348</lpage><pub-id pub-id-type="pmid">18210030</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sladek</surname><given-names>R</given-names></name><name><surname>Rocheleau</surname><given-names>G</given-names></name><name><surname>Rung</surname><given-names>J</given-names></name><name><surname>Dina</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Serre</surname><given-names>D</given-names></name><name><surname>Boutin</surname><given-names>P</given-names></name><name><surname>Vincent</surname><given-names>D</given-names></name><name><surname>Belisle</surname><given-names>A</given-names></name><name><surname>Hadjadj</surname><given-names>S</given-names></name><etal/></person-group><article-title>Agenome-wide association study identifies novel risk loci for type 2 diabetes</article-title><source>Nature</source><year>2007</year><volume>445</volume><fpage>881</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">17293876</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seki</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Glenn</surname><given-names>AS</given-names></name><name><surname>Vuguin</surname><given-names>PM</given-names></name><name><surname>FiaiIo</surname><given-names>A</given-names></name><name><surname>Du</surname><given-names>Q</given-names></name><name><surname>Ko</surname><given-names>YA</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Susztak</surname><given-names>K</given-names></name><etal/></person-group><article-title>In utero exposure to a high-fat diet programs hepatic hypermethylation and gene dysrégulation and development of metabolic syndrome in male mice</article-title><source>Endocrinology</source><year>2017</year><volume>158</volume><fpage>2860</fpage><lpage>2872</lpage><pub-id pub-id-type="pmcid">PMC5659663</pub-id><pub-id pub-id-type="pmid">28911167</pub-id><pub-id pub-id-type="doi">10.1210/en.2017-00334</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>JE</given-names></name><name><surname>Parks</surname><given-names>EJ</given-names></name></person-group><article-title>Postprandial metabolism of meal triglyceride in humans</article-title><source>Biochim Biophys Acta Mol Cell Biol Lipids</source><year>2012</year><volume>1821</volume><fpage>721</fpage><lpage>726</lpage><pub-id pub-id-type="pmcid">PMC3588585</pub-id><pub-id pub-id-type="pmid">22281699</pub-id><pub-id pub-id-type="doi">10.1016/j.bbalip.2012.01.006</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>S</given-names></name><name><surname>Anteneh</surname><given-names>H</given-names></name><name><surname>Hornisch</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>V</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Radde</surname><given-names>NE</given-names></name><name><surname>Bashtrykov</surname><given-names>P</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Jeltsch</surname><given-names>A</given-names></name></person-group><article-title>DNA sequence-dependent activity and base flipping mechanisms of DNMT1 regulate genome-wide DNA methylation</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><pub-id pub-id-type="pmcid">PMC7381644</pub-id><pub-id pub-id-type="pmid">32709850</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-17531-8</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravichandran</surname><given-names>M</given-names></name><name><surname>Rafalski</surname><given-names>D</given-names></name><name><surname>Davies</surname><given-names>CI</given-names></name><name><surname>Ortega-Recalde</surname><given-names>O</given-names></name><name><surname>Nan</surname><given-names>X</given-names></name><name><surname>Glanfield</surname><given-names>CR</given-names></name><name><surname>Kotter</surname><given-names>A</given-names></name><name><surname>Misztal</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>AH</given-names></name><name><surname>Wojciechowski</surname><given-names>M</given-names></name><etal/></person-group><article-title>Pronounced sequence specificity of the TET enzyme catalytic domain guides its cellular function</article-title><year>2022</year><pub-id pub-id-type="pmcid">PMC9451156</pub-id><pub-id pub-id-type="pmid">36070377</pub-id><pub-id pub-id-type="doi">10.1126/sciadv.abm2427</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oostrom</surname><given-names>AJHHMV</given-names></name><name><surname>Rabelink</surname><given-names>TJ</given-names></name><name><surname>Verseyden</surname><given-names>C</given-names></name><name><surname>Sijmonsma</surname><given-names>TP</given-names></name><name><surname>Plokker</surname><given-names>HWM</given-names></name><name><surname>De Jaegere</surname><given-names>PPT</given-names></name><name><surname>Cabezas</surname><given-names>MC</given-names></name></person-group><article-title>Activation of leukocytes by postprandial lipemia in healthy volunteers</article-title><source>Atherosclerosis</source><year>2004</year><volume>177</volume><fpage>175</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">15488881</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>IM</given-names></name><name><surname>Pokharel</surname><given-names>Y</given-names></name><name><surname>Dadu</surname><given-names>RT</given-names></name><name><surname>Lewis</surname><given-names>DE</given-names></name><name><surname>Hoogeveen</surname><given-names>RC</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Ballantyne</surname><given-names>CM</given-names></name></person-group><article-title>Postprandial monocyte activation in individuals with metabolic syndrome</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><year>2016</year><volume>101</volume><fpage>4195</fpage><lpage>4204</lpage><pub-id pub-id-type="pmcid">PMC5095236</pub-id><pub-id pub-id-type="pmid">27575945</pub-id><pub-id pub-id-type="doi">10.1210/jc.2016-2732</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcheva</surname><given-names>B</given-names></name><name><surname>Ramsey</surname><given-names>KM</given-names></name><name><surname>Peek</surname><given-names>CB</given-names></name><name><surname>Affinati</surname><given-names>A</given-names></name><name><surname>Maury</surname><given-names>E</given-names></name><name><surname>Bass</surname><given-names>J</given-names></name></person-group><article-title>Circadian clocks and metabolism</article-title><source>Handb Exp Pharmacol</source><year>2013</year><volume>217</volume><fpage>127</fpage><lpage>155</lpage><pub-id pub-id-type="pmcid">PMC4089089</pub-id><pub-id pub-id-type="pmid">23604478</pub-id><pub-id pub-id-type="doi">10.1007/978-3-642-25950-0_6</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cepeda</surname><given-names>M</given-names></name><name><surname>Muka</surname><given-names>T</given-names></name><name><surname>Ikram</surname><given-names>MA</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Schoufour</surname><given-names>JD</given-names></name></person-group><article-title>Seasonality of insulin resistance, glucose, and insulin among middle-aged and elderly population: The Rotterdam study</article-title><source>Journal of Clinical Endocrinology and Metabolism</source><year>2018</year><volume>103</volume><fpage>946</fpage><lpage>955</lpage><pub-id pub-id-type="pmid">29301043</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentleman</surname><given-names>RC</given-names></name><name><surname>Carey</surname><given-names>VJ</given-names></name><name><surname>Bates</surname><given-names>DM</given-names></name><name><surname>Bolstad</surname><given-names>B</given-names></name><name><surname>Dettling</surname><given-names>M</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name><name><surname>Ellis</surname><given-names>B</given-names></name><name><surname>Gautier</surname><given-names>L</given-names></name><name><surname>Ge</surname><given-names>Y</given-names></name><name><surname>Gentry</surname><given-names>J</given-names></name><etal/></person-group><article-title>Bioconductor: open software development for computational biology and bioinformatics</article-title><source>Genome Biol</source><year>2004</year><volume>5</volume><pub-id pub-id-type="pmcid">PMC545600</pub-id><pub-id pub-id-type="pmid">15461798</pub-id><pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r80</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aryee</surname><given-names>MJ</given-names></name><name><surname>Jaffe</surname><given-names>AE</given-names></name><name><surname>Corrada-Bravo</surname><given-names>H</given-names></name><name><surname>Ladd-Acosta</surname><given-names>C</given-names></name><name><surname>Feinberg</surname><given-names>AP</given-names></name><name><surname>Hansen</surname><given-names>KD</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name></person-group><article-title>Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>1363</fpage><lpage>1369</lpage><pub-id pub-id-type="pmcid">PMC4016708</pub-id><pub-id pub-id-type="pmid">24478339</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btu049</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Niu</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>JA</given-names></name></person-group><article-title>ENmix: A novel background correction method for Illumina HumanMethylation45O Beadchip</article-title><source>Nucleic Acids Res</source><year>2016</year><volume>44</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmcid">PMC4756845</pub-id><pub-id pub-id-type="pmid">26384415</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkv907</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Taylor</surname><given-names>JA</given-names></name></person-group><article-title>RCP: A novel probe design bias correction method for Illumina Methylation Beadchip</article-title><source>Bioinformatics</source><year>2016</year><fpage>2659</fpage><lpage>2663</lpage><pub-id pub-id-type="pmcid">PMC5013906</pub-id><pub-id pub-id-type="pmid">27153672</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btw285</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>P</given-names></name><name><surname>Kibbe</surname><given-names>WA</given-names></name><name><surname>Lin</surname><given-names>SM</given-names></name></person-group><article-title>lumi: A pipeline for processing Illumina microarray</article-title><source>Bioinformatics</source><year>2008</year><volume>24</volume><fpage>1547</fpage><lpage>1548</lpage><pub-id pub-id-type="pmid">18467348</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houseman</surname><given-names>EA</given-names></name><name><surname>Accomando</surname><given-names>WP</given-names></name><name><surname>Koestler</surname><given-names>DC</given-names></name><name><surname>Christensen</surname><given-names>BC</given-names></name><name><surname>Marsit</surname><given-names>CJ</given-names></name><name><surname>Nelson</surname><given-names>HH</given-names></name><name><surname>Wiencke</surname><given-names>JK</given-names></name><name><surname>Kelsey</surname><given-names>KT</given-names></name></person-group><article-title>DNA methylation arrays as surrogate measures of cell mixture distribution</article-title><source>BMC Bioinformatics</source><year>2012</year><volume>13</volume><pub-id pub-id-type="pmcid">PMC3532182</pub-id><pub-id pub-id-type="pmid">22568884</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-13-86</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><source>FastQC: a quality control tool for high throughput sequence data</source><year>2010</year><comment>Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc">http://www.bioinformatics.babraham.ac.uk/projects/fastqc</ext-link></comment></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingett</surname><given-names>SW</given-names></name><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><article-title>Fastq screen: A tool for multi-genome mapping and quality control</article-title><source>F1000Res</source><year>2018</year><volume>7</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC6124377</pub-id><pub-id pub-id-type="pmid">30254741</pub-id><pub-id pub-id-type="doi">10.12688/f1000research.15931.2</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M</given-names></name></person-group><article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title><source>EMBnet J</source><year>2011</year><volume>17</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><article-title>STAR: Ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC3530905</pub-id><pub-id pub-id-type="pmid">23104886</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Bonfield</surname><given-names>JK</given-names></name><name><surname>Liddle</surname><given-names>J</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Ohan</surname><given-names>V</given-names></name><name><surname>Pollard</surname><given-names>MO</given-names></name><name><surname>Whitwham</surname><given-names>A</given-names></name><name><surname>Keane</surname><given-names>T</given-names></name><name><surname>McCarthy</surname><given-names>SA</given-names></name><name><surname>Davies</surname><given-names>RM</given-names></name></person-group><article-title>Twelve years of SAMtools and BCFtools</article-title><source>Gigascience</source><year>2021</year><volume>10</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="pmcid">PMC7931819</pub-id><pub-id pub-id-type="pmid">33590861</pub-id><pub-id pub-id-type="doi">10.1093/gigascience/giab008</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>Featurecounts: An efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>D</given-names></name><name><surname>Mächler</surname><given-names>M</given-names></name><name><surname>Bolker</surname><given-names>BM</given-names></name><name><surname>Walker</surname><given-names>SC</given-names></name></person-group><article-title>Fitting linear mixed-effects models using Ime4</article-title><source>J StatSoftw</source><year>2015</year><volume>67</volume><pub-id pub-id-type="doi">10.18637/jss.v067.i01</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilier</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group><article-title>METAL: Fast and efficient meta-analysis of genomewide association scans</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>2190</fpage><lpage>2191</lpage><pub-id pub-id-type="pmcid">PMC2922887</pub-id><pub-id pub-id-type="pmid">20616382</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btq340</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Iterson</surname><given-names>M</given-names></name><name><surname>Van Zwet</surname><given-names>EW</given-names></name><name><surname>Heijmans</surname><given-names>BT</given-names></name></person-group><article-title>Controlling bias and inflation in association studies using the empirical null distribution</article-title><source>Genome Biol</source><year>2017</year><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmcid">PMC5273857</pub-id><pub-id pub-id-type="pmid">28129774</pub-id><pub-id pub-id-type="doi">10.1186/s13059-016-1131-9</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>EY</given-names></name><name><surname>Tan</surname><given-names>CM</given-names></name><name><surname>Kou</surname><given-names>Y</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Meirelles</surname><given-names>GV</given-names></name><name><surname>Clark</surname><given-names>NR</given-names></name><name><surname>Ma’ayan</surname><given-names>A</given-names></name></person-group><article-title>Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool</article-title><source>BMC Bioinformatics</source><year>2013</year><volume>14</volume><pub-id pub-id-type="pmcid">PMC3637064</pub-id><pub-id pub-id-type="pmid">23586463</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-14-128</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonder</surname><given-names>MJ</given-names></name><name><surname>Luijk</surname><given-names>R</given-names></name><name><surname>Zhernakova</surname><given-names>DV</given-names></name><name><surname>Moed</surname><given-names>M</given-names></name><name><surname>Deelen</surname><given-names>P</given-names></name><name><surname>Vermaat</surname><given-names>M</given-names></name><name><surname>Van Iterson</surname><given-names>M</given-names></name><name><surname>Van Dijk</surname><given-names>F</given-names></name><name><surname>Van Galen</surname><given-names>M</given-names></name><name><surname>Bot</surname><given-names>J</given-names></name><etal/></person-group><article-title>Disease variants alter transcription factor levels and methylation of their binding sites</article-title><source>Nat Genet</source><year>2017</year><volume>49</volume><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">27918535</pub-id></element-citation></ref><ref id="R106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giambartolomei</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>JZ</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Hauberg</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Boocock</surname><given-names>J</given-names></name><name><surname>Pickrell</surname><given-names>J</given-names></name><name><surname>Jaffe</surname><given-names>AE</given-names></name><name><surname>Pasaniuc</surname><given-names>B</given-names></name><name><surname>Roussos</surname><given-names>P</given-names></name></person-group><article-title>A Bayesian framework for multiple trait colocalization from summary association statistics</article-title><source>Bioinformatics</source><year>2018</year><volume>34</volume><fpage>2538</fpage><lpage>2545</lpage><pub-id pub-id-type="pmcid">PMC6061859</pub-id><pub-id pub-id-type="pmid">29579179</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bty147</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>Sampling strategy over the postprandial state <bold>(A)</bold> and the main analyses and results from this study <bold>(B).</bold> Analyses were performed using blood samples from the PREDICT and CORDIOPREV cohorts at fasting baseline, 30m and 4h after meal.</p></caption><graphic xlink:href="EMS201670-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>DNAm signals identified postprandially.</title><p><bold>A.</bold> Signals associated with postprandial lipemia at 4h in PREDICT and CORDIOPREV (n = 225 participants). Signals in blue passed the methylation meta-analysis heterogeneity filters and multiple testing correction threshold FDR = 5%. Signals above the dashed red line passed the epigenome-wide Bonferroni P-value correction threshold based on 746,953 autosomal probes. The effect sizes disp layed are based on DNAm M-values and the signals represent the sex-shared effects observed across PREDICT and CORDIOPREV. <bold>B.</bold> Trajectory of peak signals identified from the 4h meta-analysis in the PREDICT sample. <bold>C.</bold> Signals identified in the PREDICT sample across fasting baseline, 30m and 4h postprandially (n = 104 participants). Signals are ordered by their significance P-value and heatmap intensity corresponds to strength of effects. Positive and negative directions of effect are marked green and red, respectively, while non-significant effects were left blank in the heatmap. DNAm trajectories are reported with FDR = 5%. <bold>D.</bold> Examples of the shape of different DNAm trajectories identified from longitudinal DNAm analysis in PREDICT.</p></caption><graphic xlink:href="EMS201670-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Gene expression signals identified postprandially.</title><p><bold>A.</bold> Transcriptome-wide signals identified in the PREDICT sample across fasting baseline, 30m and 4h postprandially (FDR = 5%, n = 50 participants). Expression signals are ordered by their significance P-value and heatmap intensity corresponds to strength of effects. Positive and negative directions of effect are marked green and red, respectively, while non-significant effects were left blank in the heatmap. <bold>B.</bold> Volcano plot of expression signals associated with postprandial lipemia at 4h in PREDICT. <bold>C.</bold> Replication of expression signals in the GOTO cohort. Signals replicated in GOTO at 30m postprandially and their effects in GOTO and PREDICT at 30m and 4h postprandially are represented (adj. <italic>p</italic> &lt; 0.05). D. Trajectory of expression signals identified across PREDICT, GOTO and Rask-Andersen et al. (2016) over the 3 timepoints sampled in PREDICT (adj. <italic>p</italic> &lt; 0.05).</p></caption><graphic xlink:href="EMS201670-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>Colocalization of genetic effects on the DNAm levels of cg14880584 and expression of <italic>GPT2.</italic></title><p><bold>A.</bold> meQTL and eQTL results from the MeQTL EPIC Database and eQTLGen phase I for the <italic>GPT2</italic> locus, respectively. Target SNPs for were selected within 1 Mb of cg14880584 and the zoom plot shows the location of the colocalised SNP rs72812428 (chr16:46,906,797). <bold>B.</bold> Postprandial trajectory of cg14880584 and associated phenotype results for cg14880584 and <italic>GPT2</italic>. Expression at baseline, 30m and 4h are green, orange and purple in the graph, respectively. The under-regulation of <italic>GPT2</italic> captured at 30m after meal was overall linked to the glucose iAUC of participants (<italic>p</italic> &lt; 0.05).</p></caption><graphic xlink:href="EMS201670-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>DNAm signals associated with plasma glucose and blood triglycerides after meal.</title><p><bold>A.</bold> Signals identified over time, cross-sectionally and at fasting baseline in association with the interindividual response to food in PREDICT (n = 104 females). Positive and negative directions of effect with the postprandial rise in glucose and triglycerides after meal are marked green and red, respectively. Signals from genes with expression changes linked to glucose and triglycerides are highlighted in bold. DNAm and gene expression signals were considered with FDR 5% and the strongest signal was cg09661503 (<italic>SLC6A7</italic>) for triglycerides at 4h (<italic>p</italic> = 3.96E-09). <bold>B.</bold> Examples of DNAm and gene expression links to triglycerides. Where multiple timepoints are plotted together, DNAm is blue, pink and red and gene expression is green, orange and purple for fasting baseline, 30m and 4h timepoints. <bold>C.</bold> Baseline DNAm signals linked to interindividual glucose levels after meal. <bold>D.</bold> DNAm signals from the GOLDN cohort linked to triglycerides in PREDICT (adj. <italic>p</italic> &lt; 0.05). Cg17058475 (in <italic>CPT1A</italic>) was linked to the trajectory of triglycerides in PREDICT with effect most pronounced at baseline (baseline and 4h timepoints are blue and red, respectively).</p></caption><graphic xlink:href="EMS201670-f005"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Study sample characteristics (n = 225).</title></caption><table frame="box" rules="all"><thead><tr><th align="left" valign="middle"/><th align="left" valign="middle">PREDICT</th><th align="left" valign="middle">CORDIOPREV</th></tr></thead><tbody><tr><td align="left" valign="middle"><bold>n of participants</bold></td><td align="left" valign="middle">104 females</td><td align="left" valign="middle">121 males</td></tr><tr><td align="left" valign="middle"><bold>n of DNAm samples (fasting, 30m, 4h)</bold></td><td align="left" valign="middle">102, 103, 103</td><td align="left" valign="middle">117, 0, 115</td></tr><tr><td align="left" valign="middle"><bold>n of gene expression samples (fasting, 30m, 4h)</bold></td><td align="left" valign="middle">50, 49, 49</td><td align="left" valign="middle">–</td></tr><tr><td align="left" valign="middle"><bold>Age (mean ± sd)</bold></td><td align="left" valign="middle">58.97 ± 12.58</td><td align="left" valign="middle">59.09 ± 9.48</td></tr><tr><td align="left" valign="middle"><bold>BMI (mean ± sd) [kg/m<sup>2</sup>]</bold></td><td align="left" valign="middle">25.64 ± 5.28</td><td align="left" valign="middle">30.95 ± 4.24</td></tr><tr><td align="left" valign="middle"><bold>Smoking (never, ex, current)</bold></td><td align="left" valign="middle">58, 42, 4</td><td align="left" valign="middle">24, 81, 16</td></tr></tbody></table></table-wrap></floats-group></article>